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ABBREVIATIONS
AchE Acetyl cholinesterase
ADI Acceptable daily ntake
BCF Bioconcentration factor
BF Bottom fraction
CAT Chloramphenicol acetyltransferase
CHB Chlorinated bornane
ChE Cholinesterase
CTT Compound of technical toxaphene
DDE 4,4-Dichlorodiphenyl,2,2-dichloroethene
DDT 4,4-Dichlorodiphenyl,2,2,2-trichloroethane
ECD Electron capture detector
EI Electron impact
EF Enantiomer fraction
ER Enantiomer ratios
ERE Estrogen-responsive element
E-RmNASF Estrogen-regulated mRNA stabilising factor
FAO Food and agriculture organization of the united nations
GC Gas chromatography
GJIC Gap junctional intercellular communication
GPC Gel permeation chromatography
H Henry’s law constant
HCB Hexachlorobenzene
HDL High density lipoproteins
HPLC High performance liquid chromatography
i.p. Intra peritoneal
i.v. Intra venous
IUPAC International union of pure and aplied chemistry
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Kow Octanol-water partition coefficient
LDL Low density lipoproteins
LOD Limit of determination
MATT Investigation into the monitoring, analysis and toxicity of toxaphene
MDGC Multidimensional gas chromatography
MFO Mixed-function oxygenase
MRL Maximum residue limit
MS Mass spectrometry
NCI Negative chemical ionisation
NHL Non-Hodgkin’s lymphoma
NOAEL No observed adverse effect level
PCB Polychlorinated biphenyl
PCC Polychlorinated camphene
PKC Protein kinase C
PPI Pressure pulse injection
RI Retention indices
SCE Sister-chromatid exchange
SIM Selected ion monitoring
USEPA United States environmental protection agency
VLDL Very low density lipoproteins
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SUMMARY
Toxaphene production, in quantities similar to those of PCBs, has resulted in high toxaphene
levels in fish from the Great Lakes and in Arctic marine mammals (up to 10 and 16 µg g-1
lipid). The total toxaphene data suffer from a large variability. Consequently, little can reliably
be said about trends or geographical differences in toxaphene concentrations. New
developments in mass spectrometric detection, using either negative chemical ionisation or
electron impact modes as well as in multi-dimensional gas chromatography have recently led to
congener specific approaches.
Recently, several nomenclature systems have been developed for toxaphene
compounds. Although all systems have some specific advantages and limitations, it is
suggested that an international body like IUPAC make a decision on this subject to obtain
uniformity in the literature.
Toxicological information on individual chlorobornanes is scarce but some first reports
have recently appeared. Neurotoxic effects of toxaphene exposure, such as effects on
behaviour and learning have been reported to occur. Technical toxaphene and some individual
congeners were found to be weakly oestrogenic in vitro test systems, in vivo no evidence for
endocrine effects has been reported. In vitro, technical toxaphene and toxaphene congeners
have been shown to be mutagenic. However, in vi o studies have not shown genotoxicity,
rather a non-genotoxic mechanism is proposed. Nevertheless, toxaphene is regarded to present
a potential carcinogenic risk to humans.
A legal tolerance level for toxaphene (0.1 mg kg-1 wet weight for fish) has until now
only been established in Germany.
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INTRODUCTION
Toxaphene, a complex mixture of polychlorinated camphenes, was first introduced in 1945 by
Hercules Co. as Hercules 3965. Until the mid 1980s, it was mass produced and widely used as
an insecticide, particularly in the cotton growing industry. It was also used as a piscicide to
control rough fish in various water systems (1). The lipophilic, persistent, and volatile nature of
toxaphene, have contributed to its global dispersion throughout the fresh water and marine
environment. It has even been found in remote areas such as the Arctic (2) where the pesticide
was never used. In addition to bioaccumulation in biota inhabiting these regions, it is also been
detected in humans (3-10). Toxaphene was banned by the US Environmental Protection
Agency in 1982, this example was followed by many countries. However, in the early 1990s
the detection of toxaphene in marine fish in Europe caused concern with regard to human
health in relation to fish consumption. Attention to toxaphene has increased, both in the
analytical and the toxicological field. A major impulse to research in this field was initiated by
the synthesis of individual compounds of toxaphene and the commercial availability of them
(11,12). By using individual standards it is possible to gain more insight into the transport, fate
and toxicological effects of toxaphene in the environment. The determination of individual
congeners provides more detailed information but this also leads to more complicated analyses.
Another problem lies in the nomenclature of individual compounds. Some proposals for
simpler codes than the systematic nomenclature have been published recently and will be
discussed.
In 1997 a European research project entitled “Investigation into the monitoring,
analysis and toxicity of toxaphene” (MATT) started. As part of this project an update of
available knowledge on the developments in toxaphene analysis, new environmental data and
toxicology is presented. To avoid duplication of the extensive review on toxaphene published
by Saleh in 1991 (1), this review concentrates on developments since 1990.
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PHYSICAL AND CHEMICAL PROPERTIES
Toxaphene (CAS No. 8001-35-2) was one of the main products produced by the Hercules
company in the USA (1). The process consists of the extraction of crude a-pinene from pine
stumps, using methylisobutylketone, heat and pressure. Isomerisation of the a-pinene produces
camphene, bornylene and a -terpineol. The camphene was subsequently chlorinated under UV
light to produce toxaphene. The average chlorine content is 67-69% (13). The structure of the
main components of toxaphene is given in figure 1.
Toxaphene is a yellow, waxy solid with a mild terpene odour, softening in the range of
343 to 363 K. While readily soluble in most organic solvents, it is more soluble in aromatic
than aliphatic hydrocarbons. Its average elemental composition is C10H10Cl8 (1). Fingerling et
al. (14) state that toxaphene consists of at least 180-190 components mostly with the formula
C10H18-nCln or C10H16-nCln where n is 6-10. Buser et al. (15) report that polychlorobornanes
(C10H18-nCln where n = 5-12) are formed as the main components in a Wagner-Meerwin type
rearrangement reaction. The peak area percentage of all components identified, measured
using the electron capture detector (ECD), amounts to 50% of the total toxaphene area (1).
The commercial product is relatively stable, but may be degraded by loosing HCl or Cl2
on prolonged exposure to sunlight, alkali, or temperatures above 393 K (16). Saleh (1) states
that technical toxaphene does not undergo a serious change when exposed to normal sunlight.
Saleh and Casida (17) and Parlar et al. (18) reported that irradiation at wavelengths below 290
nm results in reductive dechlorination and dehydrochlorination. Radiation above 290 nm does
not seem to affect toxaphene composition. When adsorbed on silica, however, technical
toxaphene is completely mineralised to CO2 and HCl at 230 nm (19).
A specific gravity of 1.6 kg l-1 has been reported for technical toxaphene (20). Th
vapour pressure and the log octanol-water partition coefficient (Kow) value have been
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estimated to be comparable to that of hexachlorobenzene (HCB), 1.73 10-3 Pa at 298 K (21),
and a log Kow of 5.5 (22). Howard (23) and Sullivan and Armstrong (24) have recorded Kow
values of 4.82 to 6.4, respectively. A log Kow value of 6.44 was recorded by Hooper et al. (25).
This is somewhat lower than that of technical PCB mixtures but higher than those of p,p’-DDT
and its metabolites, suggesting that the bioconcentration of toxaphene would be high. These
data are difficult to compare due to the variation of mixtures used. Bioconcentration factors
(BCFs) of 2 x 106 have been observed by Kucklick et al. (26) for toxaphene in Arctic cod. This
value is higher than predicted from the log Kow. Based on their vapour pressure calculations
Wania and Mackay (27) have suggested that toxaphene changes its characteristic of being a
chemical which is mostly in the gas-phase, to one which is largely aerosol-absorbed within the
range of global environmental temperatures. At 298 K less than 10% is adsorbed to aerosols,
at 253 K almost 90% is adsorbed. This implies that with this change of temperature, almost all
of the toxaphene in air condenses onto particles present in the atmosphere and thus becomes
subject to wet and dry deposition. Essentially at low temperatures toxaphene is more rapidly
transferred from the atmosphere to soil and water.
The water solubility of toxaphene has been reported with an equally broad spectrum of
values, these range from 0.4 mg l-1 at 298 K (28), and 0.55 to 3.3 mg kg-1 at 293 to 298 K
(24).
The most important factor determining the flux between the air-water interface is the
Henry’s law constant (H). Murphy et al. (29) measured H for a technical mixture of toxaphene
congeners as being 0.62 Pa m3 mol-1 at 293 K. Using fugacity-based equations (22,30), the
direction and magnitude of the flux can be calculated, as was done by McConnel et al. (31),
who assumed that the temperature slope of Tateya et al. (32) for PCBs is valid for toxaphene
as well. With the insertion of the measured H, a toxaphene specific intercept can be determined
and from that a temperature corrected H can be obtained. This value allows the direction of the
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flux to be calculated. Such calculations have suggested that up to 2 kg of material will be
deposited on Lake Baikal per month by gas exchange, this process being further enhanced by
the low water temperature of the lake (32). More accurate congener specific H values are
required to improve these estimations. This flux direction of air to water has also been
recorded by Bidleman et al. (33). Hoff et al. (34) report that additional inputs via precipitation
and particle deposition are likely to be ten to twenty times smaller than those from gas
absorption.
Most chlorinated bornanes contain at least one chlorine atom at C2 and C10, while the
bridging carbons, C1 and C4, are non-chlorinated (35). Technical toxaphene, as it is
synthesized by photoinduction, will have a high percentage of components containing a
dichloro group in the C2 position (36).
Toxaphene congeners demonstrate a different stability to UV light, acid and alkaline
treatment. Fingerling et al. (14,36) demonstrated that in soil 2,2,5-endo,6-exo,8,9,10-
heptachlorobornane, 2,2,5-endo,6-exo,8,8,9,10-octachlorobornane, 2,2,5-endo,6-
exo,8,9,9,10-octachlorobornane, 2,2,3-exo,5-endo,6-exo,8,9,9,10-nonachlorobornane, 2,2,5-
endo,6-exo,8,8,9,10,10-nonachlorobornane and 2,2,5-endo,6-exo,8,9,9,10,10-
nonachlorobornane (B[30012]-(111), B[30012]-(211), B[30012]-(121), B[32012]-(121),
B[30012]-(212) and B[30012]-(122) according to Ref. (37) and Nomenclature section) were
all dechlorinated by reductive removal of one chlorine atom from each geminal dichloro group,
beginning with that in the C2 position which is the most labile under anaerobic conditions. The
authors suggest that dechlorination also occurs during photodegradation and that the
dechlorination rate nonachlorobornanes > octachlorobornane > heptachlorobornanes.
Fingerling et al. (14) also found that during irradiation in solvents, the bornane
structure is generally preserved and that photoability seems to depend on the presence of a
geminal dichloro group in C2-position. The dechlorination rate is enhanced by an additional
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chlorine atom in the C3-position but not by a dichloro group in C5-position. Components with
only a single chlorine atom at each secondary ring atom in alternating orientation, such as 2-
endo,3-exo,5-endo,6-exo,8,8,10,10-octachlorobornane, 2-endo,3-exo,5-endo,6-
exo,8,8,9,10,10-nonachlorobornane, or 2-endo,3-exo,5-endo,6-exo,8,9,9,10,10-
nonachlorobornane (B[12012]-(202), B[12012]-(212), or B[12012]-(212), according to Ref.
(37) and Nomenclature section), have been found to be extremely photostable.
SOURCES
The Hercules Company first introduced toxaphene as an insecticide in the late 1940’s (1). In
the ensuing years it had a variety of uses until it was ultimately banned by the United States
Environmental Protection Agency (USEPA) in 1982 because it was suspected of being a
probable human carcinogen and persistent hazardous compound to non target organisms. A
stipulation existed that stocks could be used through 1986 as reported by Voldner and Smith
(38) and Rapaport and Eisenreich (39). By that year usage had dropped from a reported 45 x
106 kg year-1 to 7.20 x 106 kg year-1. Over 180 companies are reported to have produced
toxaphene since 1947 with various product names (1 a d Table 1).
In 1989 there were 168 registered uses in the USA (40), and more than 277 worldwide
for agricultural commodities and crops to control 167 major insect pests. Its use in livestock
dips as a miticide, and in lakes as a piscicide to control rough fish populations have all been
widely reported (1). The interpolated total global use between 1950 to 1993 was 1,330 x 106
kg and from 1970 to 1993 was 670 x 106 kg (4 ). This estimation was based on literature data
and contacts with international agencies and researchers, its quality varies and shows large
spatial and temporal gaps.
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The USA (42), the Central American states, and the former Soviet states have had the
highest recorded usage. This may be, because more detailed information on usage was received
from these countries whereas information is not kept or is confidential in others (41).
El-Sebae et al. (28) report that toxaphene continues to be used in African countries
especially Ethiopia, Sudan, Tanzania and Uganda where field run-off eventually leads to the
Nile and ultimately the Mediterranean Sea. These could act an additional reservoir for future
contamination. Information is lacking for other African countries.
In 1970 toxaphene was used in a formulation called ‘polydophen’ comprising of 20%
DDT and 40% toxaphene in a diesel fuel oil solvent. This was recommended as a substitute for
DDT in Central Asia (31). Bidleman et al. (43) and Voldner and Schroeder (44) stated that
application likely continues in Soviet states, Mexico, Romania, Hungary, Poland and the Indian
Subcontinent in addition to many African Nations, Nicaragua and Mexico.
The most recent data available on toxaphene usage from the FAO (as reported by
Swackhamer et al. (45)) indicates that Korea and Mexico were the only countries using
toxaphene into the 1980’s, Mexico reported usage of 600 tonnes in 1985.
Toxaphene is currently banned in many countries world-wide. Argentina and Mexico
however allow restricted use. Toxaphene was only used in small quantities in Sweden and has
been banned since 1956 (46).
In 1971 the Soviet government restricted the use of toxaphene, it is thought to be still
in use as an insecticide for sugar beet, peas, potatoes, mustard, rape and perennial herbs in the
following formulation; 50% active ingredient, 30% oil, 15% amalgamate at 1.6-3.0 kg ha-1
during sprout stage (47). Voldner and Li (41) state that 1 x 108 kg has been used since 1970 in
the former Soviet Union.
In 1956 toxaphene was recommended for nation-wide use in Egypt as a protective
insecticide against cotton leafworm, pink bollworm and spiny bollworm on cotton fields. Field
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efficacy was the only consideration for the use. It was applied as a formulated emulsifiable
concentrate of toxaphene (60% chlorinated camphene) used in four successive sprays during
the cotton season. This method of administration caused a maximum contamination of soil and
can result in up to 20% being lost to air, 20-50% lost to soil and 20-50% lost to water
systems. This can ultimately lead to air and groundwater pollution and soil contamination. A
concentration of 10 ppm has been reported in Egyptian soil, biota and water (1). Although the
dosage applied doubled between 1956 and 1961, major crop losses were experienced as
efficacy decreased and resistance helped by the removal of the insect’s natural enemies became
a problem. Egypt alone used 54 x 103 kg toxaphene between 1956-61, which was estimated at
25% of the Non-US usage of toxaphene (28). The level of resistance conferred to cotton
leafworm was 26-fold compared to the laboratory controls. This led to the banning in Egypt of
toxaphene in 1961, not for its environmental impact but for its poor efficacy factor.
It was previously thought that chlorohydrocarbons were produced in chloro-bleaching
from the residual monoterpenes in the wood pulp industry. However, no indication of
compounds identical to the main congeners in commercial toxaphene was found. This proved
that toxaphene in fish did not originate from chlorobleaching of pulp (48). However,
chlorinated camphenes are present in pulp mill recipients (49). Chlorine bleaching of wood
pulp produces chlorinated compounds that are similar in composition to toxaphene but with
lower chlorine content (50).
Rappe et al. (51) reported that the main chlorobornanes Tox9, TC1, TC2, TC6 and
TC7, which are most likely 2-endo,3-exo,5-endo,6-exo,8,8,10,10-octachlorobornane, 2-
endo,3-exo,5-endo,6-exo,8,9,10-heptachlorobornane, a so far unknown heptachlorobornane,
2-exo,3-endo,5-exo,8,9,9,10,10-octachlorobornane and 2-exo,5,5,8,9,9,10,10-
octachlorobornane (B[12012]-(212), B[12012]-(111), ?, B[21020]-(122) and B[20030]-(122),
according to Ref. (37) and Nomenclature section), respectively (52,15), were detected in
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samples close to pulp mill. These chlorobornanes were probably due to aerial transport and
degradation in the sediment. Additional chlorobornanes (in particular hexachloro congeners)
were observed in some samples that were closer to the pulp mill, (4 km as opposed to 150
km.).
Toxaphene usage in the Great Lakes of North America
Much of the research on toxaphene has been carried out in the Great Lakes of North America
with some conflicting data on the sources of the pollutant. These range from its use as a
piscicide to the contribution of the wood pulp industry in addition to atmospheric sources.
Swackhamer et al. (53) state that approximately 1% or less of the US use was used in the
Great Lakes basin (54). The rate of use in the basin was ca. 1 x 106 kg year-1 between 1970-
77, and would have peaked around 1977. Thus the presence of toxaphene in the Great Lakes
has been largely attributed to long-range atmospheric transport from the southern US or
Central America, followed by wet and dry deposition to the lakes (55,56).
Historical investigation of the records of Lake Michigan showed that 224 x 103 kg of
toxaphene was used in the Green Bay watershed between 1950-80, with most being used as a
pesticide on cropland but some on livestock and in lakes as a piscicide. It has been stated that
even if there were only a 1% run-off into Lake Michigan this would represent a large fraction
of the estimated inventory of toxaphene in the lake, i.e. 11 x 103 kg (57).
Inputs from the atmosphere to water surfaces such as the Great Lakes include dry
fallout of particulate associated contaminants, washout of gas phase and particulate phase
contaminants by precipitation events and gas transfer across the air-water interface (58).
Oehme et al. (10) reported that the continual process of transport, deposition, revolatilisation
and new transport along a decreasing temperature system will result in accumulation of
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toxaphene in sediments as the vapour pressure becomes so low that it restricts the atmospheric
transport.
In the 1960’s several lakes in Wisconsin were treated with toxaphene to kill rough fish.
Kidd et al. (9) reported that the concentration of toxaphene in fish in Laberge, Canada was
entirely due to atmospheric input followed by long food chain bioaccumulation giving
hazardous fish concentrations. Kidd et al. (9) provides further information on possible sources
and reports that some contamination of Lake Ontario was due to surreptitious dumping.
Howdeshell and Hites (59) claim that the Niagara River is the main riverine source of
sediment and water to Lake Ontario and therefore likely to be source of some toxaphene in the
lake with atmospheric deposition being important also.
Scheel (60) report that toxaphene-like contaminants found in Michigan sport lakes may
not be completely due to the presence of toxaphene compounds. It was suggested that they
might be due to a mixture of chlorinated bicyclic monoterpenes including the chlorinated
pinenes, occurring as the unwanted bi-products from the chlorination of naturally occurring
plant derived product materials. Results suggest that not all chlorinated bicyclic monoterpenes
found in fish tissue may be the result of chlorinated camphenes or camphanes from toxaphene
but from other sources. These may come from the natural product family of bicyclic
monoterpenes including pinene and borneol (61).
NOMENCLATURE
For many years it was assumed that the pesticide toxaphene primarily consisted of chlorinated
bornanes in addition to small amounts of chlorinated bornenes and even smaller amounts of
chlorinated bornadienes (62). The existence of bornenes and bornadienes was based on data
obtained with gas chromatography (GC) with negative chemical ionisation mass spectrometry
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(NCI/MS) studies. Mass spectra with fragments 2 or 4 amu below the [M-Cl]- ions of
bornanes, were interpreted as bornenes and bornadienes. However, new insights in synthetic
pathways of technical toxaphene indicate the formation of camphenes and dihydrocamphenes
(63). Therefore, the observed mass spectra should probably mainly be attributed to chlorinated
camphenes and dihydrocamphenes. According to Saleh (62), the technical mixture also
consists of small amounts of other chlorinated hydrocarbons and non-chlorinated
hydrocarbons.
As can be seen from Table 1, the total number of theoretical congeners calculated from
the formula from Vetter (64) from all five classes of compounds is extensive. At present, 61
compounds of technical toxaphene have been identified (65); these chlorinated compounds
consist of 48 bornanes, 6 bornenes, 1 bornadiene, 5 camphenes and 1 dihydrocamphene.
Nevertheless, the number of congeners can easily lead to confusion in systematic names and
nomenclatures, especially because many of them are enantiomers.
Based on structural considerations, Hainzl et al. calculated that 138 bornane and 59
camphene congeners may be found at significant concentrations worth mentioning, using an a-
chiral separation (66). Jansson and Wideqvist (67) reported the separation of 670 individual
components in technical toxaphene. Zhu et al. (68) recorded more than 300 penta- to
decachlorobornanes and bornene/camphene isomers after collection of five fractions from high
performance liquid chromatography (HPLC) on silica gel, while they found only 76 partially
resolved peaks with possible co-elution in a total ion chromatogram (150-500 amu) when the
mixture was not pre-separated, GC-NCI/MS detection being utilised in both instances. De
Boer et al. found 246 compound peaks in technical toxaphene using two-dimensional heart-cut
GC using ECD while only 107 peaks were found using a single column GC-ECD set-up (69).
Trade names, names of classes of compounds
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Although toxaphene is the most commonly used name, a wide variety of (trade) names exists
(Table 2) (65,70,71). Other names used for toxaphene are: compounds of technical toxaphene
(CTTs) (71), polychlorinated monoterpenes (71), polychlorinated camphenes (PCCs) (72),
polychlorinated terpenes (25) and chlorinated bornanes (CHBs) (73), where several of these
names only contain one of the groups present in the technical mixture.
The variety of trade and common names used for toxaphene, in addition to the use of
trivial names of some of the compound classes referred to in Table 1, complicate the field of
nomenclature. Names that are no longer supported by IUPAC, like ‘norbornanes’ and
‘camphanes’ for bornanes and ‘iso-camphanes’ for dihydrocamphenes compound the problem.
Systematic names
For all groups of compounds mentioned above (Table 1) it is a complex task to formulate
systematic names, which are in agreement with IUPAC rules. The structure of these
compounds is given in Figure 1. The generally accepted systematic nomenclature for bornanes,
according to IUPAC rules, is based on the following rules and agreements (Figure 1A)
(74,75):
- Numbering of the carbon atoms, as shown in Figure 1A (as presented by IUPAC).
- Substituents on the six-membered ring that point downwards are in the endo position and
substituents that point upwards are in the exo position (the bridging carbon, C7, is above
the ring).
- The carbon atom above the C2 - C3 bond is C9, the carbon above C5 - C6 is C8.
- The lowest possible numbering should be applied:
The carbon neighbouring C1 is decisive for the direction of numbering. If both carbons
neighbouring C1 bear the same number of chlorine atoms, then the substitution of the next
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carbon in the ring is decisive in deciding the direction of numbering. If these are also
equivalent, the first carbon with an endo chlorine determines the direction of numbering.
- Enantiomers receive the same systematic nomenclature.
For bornenes (Figure 1B) and bornadienes (Figure 1C) the following agreements and additonal
rules should be applied:
- If one double bond is present, the carbon atoms at this bond are numbered C2 and C3.
- If two double bonds are present, the numbering of the six-membered ring should result in
the lowest possible numbers, as with the bornanes.
- As with the bornanes, the C9 carbon should be positioned over the C2 - C3 double bond.
For chlorinated camphenes (Figure 1D) and dihydrocamphenes (Figure 1E) the systematic
names are even more complicated than for the chlorinated bornanes, bornenes and
bornadienes. Coelhan and Parlar state that the systematic name for non-substituted camphene
should be 2,2-dimethyl-3-methylene-8,9,10-trinorbornane and that other substituted
camphenes should be regarded as derivatives of 8,9,10-trinorbornane (75). H wev r,
according to Vetter (76), IUPAC has abolished the name norbornane, which was used to
indicate the bornane structure without C8, C9 and C10. In addition, regarding chlorinated
camphenes and dihydrocamphenes as chlorinated 8,9,10-trinorbornanes, creates even longer
systematic names. Moreover, such names would be strongly dependent on the substituents
present.
Systematic names for chlorinated camphenes and dihydrocamphenes can also be
regarded as being derived from bicyclo(2.2.1)heptane as the basic structure (64,75). The non-
substituted bornane would then become 1.7.7-trimethyl-bicyclo(2.2.1)heptane. Camphene, and
dihydrocamphene would be referred to as 2,2-dimethyl-3-methylene-bicyclo(2.2.1)heptane and
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2,2,3-trimethyl-bicyclo(2.2.1) heptane, respectively. Chlorinated camphenes and
dihydrocamphenes will receive very long systematic names, which easily leads to confusion.
Hainzl (63) proposed systematic names based on a fixed numbering of the camphene
skeleton (Figure 1E). This approach is quite straightforward, resembles the bornane
nomenclature and is more user-friendly. However, assigning these fixed numbers is not yet
supported by IUPAC and, in addition, there are still no IUPAC rules for the designation of the
C8 and C9 orientations in camphene (76).
Nomenclature systems
Because the chlorinated bornanes are the most abundant compounds in technical toxaphene,
most attention has been devoted to them, both with regard to analytical method development
and monitoring, and nomenclature. In the past the systematic nomenclature of the bornane
skeleton has been non-uniform because several authors cited the IUPAC nomenclature
incorrectly, particularly the C8 and C9 positions (Figure 1) (74). Difficulties in formulating the
correct systematic names for chlorinated bornanes were solved when IUPAC presented the
definitive numbering of the carbon skeleton.
Because of the extensive systematic names for chlorinated bornanes (e.g., 2-endo,3-
exo,5-endo,6-exo,8,9,9,10,10-nonachlorobornane), isolated congeners were often indicated by
more simple names, such as ‘T12’, ‘Toxicant A’, Toxicant Ac’, ‘Toxicant B’, ‘TOX8’ and
‘TOX9’, however, a clear nomenclature system was absent. Several authors have proposed
and used more systematic nomenclatures in an attempt to remedy this situation. Table 3 gives
an overview of these nomenclatures which will be discussed below.
The nomenclature used by Parlar et al. is based on gas chromatographic retention on a
certain stationary phase (11,77). The nomenclature simply consists of a two-digit code,
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representing a peak in the technical mixture. The nomenclature can be applied to chlorinated
bornanes, camphenes and dihydrocamphenes.
To indicate enantiomers, an additional code, ‘+’ or ‘-’, is proposed. However, apart
from the fact that the code does not provide any structural information, one also has to
consider that (i) with such large numbers of congeners, coelution cannot be excluded (69),
Parlar No. 42, for example, represents at least two different chlorobornanes (77); (ii) the
chlorinated bornanes, camphenes and dihydrocamphenes will be part of the same coding
system without any class distinction; (iii) the theoretical number of chlorinated bornanes,
camphenes and dihydrocamphenes will require many thousands of codes and will become at
least four-digit. At the present time 17 chlorinated bornanes and five chlorinated camphenes
have been reported as Parlar numbers (Table 3).
A binary coding system for chlorinated bornanes was proposed by Nikiforov et al. (78).
The possible chlorination positions were ordered according to the IUPAC order of preference
into a 13-digit binary number. A ‘1’ is assigned if a chlorine is present and a ‘0’, if not. This
binary number is then converted into a short 4-digit decimal number. However, as will be
evident from the above, five out of the maximum number of eighteen substitution positions had
to be fixed. This was done on the basis of the assumption that environmentally important
congeners have at least one chlorine at C10, not more than two chlorines at C8, C9 and C10
and no chlorine at C4. Because of this assumption the code can be limited to four digits instead
of six, but cannot be used for all the theoretically possible congeners. Applying the
nomenclature to 2,2,5-endo,6-exo,8,9,10-heptachloroborane (see Figure 2A) results in the
code HpCB-6452, where the characters are the acronym for heptachloroborane. However, the
enantiomer given in Figure 2B, which is chlorinated at positions 2-exo,3-endo,6,6,8,9,10
would have the code HpCB-3188. The IUPAC rule for systematic numbering is to obtain the
lowest possible numbering, and, therefore, the code HpCB-3188 would be selected, while that
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represents the incorrect systematic name. The most important limitation is that it is not very
easy to convert binary and decimal codes into each other and the help of a computer is
desirable for rapid conversion. The general code becomes:
212*2-endo + 211*2-exo + 210*3-endo + 29*3-exo + 28*5-endo + 27*5-exo + 26*6-endo +
25*6-exo + 24*8a + 23*8b + 22*9a + 21*9b + 20*(second chlorine substituent to C10)
Oehme and Kallenborn (79) also proposed a nomenclature for chlorinated bornanes
based on a binary number representing all possible chlorination positions, followed by
conversion into a decimal code. The positions at the six-membered ring and at the three methyl
groups are numbered separately, which results in two three-digit decimal numbers at
maximum, separated by a hyphen. This was done in order to prevent a code with a maximum
of six digits, which would be necessary if all possible positions are included in a single code.
For example, the enantiomers of Figure 2 are represented by the code 195-421, however, a
distinction between the enantiomers is absent. The advantage of this system over the previous
one is that related structures have similar codes. However, the basic bornane structure used by
the authors is not according to IUPAC rules, because the C8 and C9 atoms are reversed (74).
Care should be taken when decoding the first part of the code: the binary nine-digit number
should be read from the right to the left starting with 2-exo. This was done incorrectly in Ref.
(81), which, subsequently, was cited in Refs. (16,37). Thus, decoding of the three-digit number
to reveal the chemical structure is not simple, structural information therefore is not directly
available. The general code becomes:
20*2-exo + 21*2-endo + 22*3-exo + 23*3-endo + 24*4 + 25*5-exo +
26*5-endo + 27*6-exo + 28*6-endo (first part)
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20*8a + 21*8b + 22*8c (first digit second part)
20*9a + 21*9b + 22*9c (second digit second part)
20*10a + 21*10b + 22*10c (third digit second part)
Andrews and Vetter proposed a systematic nomenclature for chlorinated bornanes by
listing them in order of preference according to IUPAC rules (74). The congeners were split
into series of homologues to restrict the code length to less than five digits, which would be
necessary if all possible congeners are tabulated in the same way as is done for chlorinated
biphenyls (82). In this way the maximum number of digits is four. The code is preceded by a
character to indicate whether the compound is a b r ane (B), camphene (C), bornadiene, (D)
or bornene (E) and a number denoting the degree of chlorination (1-18). For example, the
enantiomers shown in Figure 2 are coded B7-515 and are distinguished by an ‘a’ or ‘b’, but ‘b’
coded enantiomers correspond to incorrect structural names (71), if IUPAC rules are applied.
The disadvantage of the method is that structural information can only be obtained after
consultation of extensive tables or by using a computer programme which, until now, are
available for chlorinated bornanes only.
Wester et al. (37) proposed a nomenclature which can be regarded as a mixture of the
nomenclatures mentioned above, with the advantages that structural information can be
directly deduced, and that the nomenclature is applicable to chlorinated bornanes as well as
chlorinated bornenes and bornadienes. The proposed nomenclature yields a code consisting of
two parts. The digits in the first part of the code reflect the degree of chlorination of carbons
C2 - C6, presented according to the rules of Table 4. C4, i.e. the third digit, can only have
code 0 or 1. In the second part the digits simply indicate the number of chlorine atoms of C8 -
C10. ‘B’ precedes the 8-digit number in the case of bornanes. For example, 2-endo,3-exo,5-
Geus, H.-J. de, et al. Toxaphene: occurrence, analysis and toxicology
22
endo,6-exo,8,8,9,10,10-nonachlorobornane will be presented as B[12012]-(212). The code for
the conformation of the enantiomer would be B[21021]-(122), this clockwise numbering is
arrived at by simply reversing the first part of the code and exchanging the digits for the C8
and C9 positions. Hence, because of the IUPAC rules, B[12012]-(212) is the only correct
representation for both enantiomers. To differentiate both enantiomers ‘r’ is proposed for
clock-wise numbering of the six-membered ring (Figure 2A: B[30012]-(111)r ) and ‘s’ for
anti-clockwise numbering (Figure 2B: B[30012]-(111)s ), provided the bridging carbon atom
(C7) is above the ring. The advantage of this notation is that it is related to the generally
accepted notation for chirality (R/S), and enantiomers receive the same code. For racemates,
the r/s notation can be left out.
Another advantage of this nomenclature is the simplicity in establishing whether a
congener has an enantiomer or not. For example: 2,2,3-endo,5-endo,6,6,8,9,10-
nonachlorobornane, coded as B[31013]-(111), has no enantiomer: reversing the first part and
exchanging the digits representing the number of chlorine atoms at the C8 and C9 position,
gives the same code.
The nomenclature proposed by Wester et al. (37) w s extended to include bornenes
and bornadienes which can easily be done because of structural similarity. Only one chlorine
atom can be attached to a carbon atom participating in a double bond. To such a carbon, only
‘0’ or ‘1’ can be assigned. For example, 2,5-endo,6-exo,8,9,9,10,10-octachloroborn-2-ene will
receive the code E[10012]-(122), and 2,3,5,8,8,9,10-heptachloroborna-2,5-diene will be coded
D[11010]-(211). For enantiomers, the r/s nomenclature can be used, and is left out in the case
of a racemic mixture or if there are no enantiomers.
The structures of polychlorinated camphenes and dihydrocamphenes could not be
represented by codes based on the system described above because their structures differ too
much. However, Wester et al. developed a coding system based on the same logic (80). The
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numbering of the carbon atoms in the skeleton is the same as proposed by Hainzl (83);
however, the ‘a’ and ‘b’ indication of the substituents at C10 (63) have been replaced by ‘E’
(trans) and ‘Z’ (cis) respectively (Figure 2A). As can be seen from Figure 1, there is a strong
resemblance with the clockwise numbering of the bornane carbon skeleton (37).
Figure 1D shows that there is no need to consider arbons C5 and C6, because they
cannot be chlorinated. The first part of the code deals with the substituents at carbons C1 - C4,
C7 and C10. Carbons C1 and C4 can only have one chlorine substituent and these will be
invariably in the endo position. Substitution at carbons C2 and C3 can be denoted according to
the rules of Table 2. For carbon C7, the positions of the substituents have to be defined. A ‘0’
is assigned for no substitution, ‘1’ for substitution in the ‘a’ position, ‘2’ for substitution in the
‘b’ position and ‘3’ for two substituents. For C10 the known ‘E’ (trans) nomenclature
corresponds with code 1 and ‘Z’ (cis) with code 2. Carbons C8 and C9 are dealt with in the
second part of the proposed code which merely reflects the number of chlorine substituents at
C8 and C9. Finally, the code is preceded by C for camphenes (74), with enantiomers being
distinguished by an ‘r’ or ‘s’ according to Ref. (37). The general code then becomes:
C[code C1, code C2, code C3, code C4, code C7, code C10]-(code C8, code C9)r/s.
The same logic as was used above, can be applied to the dihydrocamphenes (Figure
1E). There is no need to consider carbon C5, since chlorination cannot occur. As regards the
first part of the code: for carbons C1 - C4 and C7 the same rules are applied as for the
chlorinated camphenes. Carbon C6 can only have one substituent which can be in the endo or
exo position and the rules of table 2 were applied. However, if C6 is not chlorinated, it will not
be clear in which position the hydrogen atom is. A subscript, selected according to the rules of
table 2, is then used to denote the endo or exo position of the hydrogen atom. The second part
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of the code deals with C8 - C10, with the code reflecting the number of chlorine substituents.
Finally, the code is preceded by DC (dihydrocamphenes) and enantiomers are distinguished by
adding an ‘r’ or ‘s’ according to Ref. (37). The general code then becomes:
DC[code C1, code C2, code C3, code C4, code C6subscript H6, code C7]-(code C8, code C9,
code C10)r/s.
ANALYTICAL METHODS
The determination of ‘total toxaphene’ as is mostly performed may involve a large over- or
under-estimate of the true concentration since the peak pattern of the sample under study does
not resemble that of the standard. In the environment peak patterns may be considerably
altered (84,85) but there also exists a large difference between the commercially available
technical toxaphene standards. Using various technical standards Carlin and Hoffman (86)
found variations between 19 and 131% compared to their laboratory standard. Furthermore,
the detector response is in general not equal for all congeners. However, the most relevant
question may be; what does a total concentration imply when the composition is unknown?
Because of this the trend at present is towards congener-specific approaches, which are
possible after the first isolation and synthesis of individual compounds (87,88). About thirty
individual congeners are commercially available so far. In general it can be said that for
comparison of monitoring results it is important that authors report the full analytical
procedure used, because different methods can cause large variations in the results and
ultimately lead to incorrect conclusions being recorded.
Extraction
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Little attention has been paid to the efficiency of extraction procedures. However, it is thought
that extraction procedures which are suitable for related compounds such as PCBs, DDT and
chlordanes could also be used for toxaphene compounds due to their lipophilic and structural
similarities (73).
Pre-separation / clean-up
Several stationary phases have been used in the sample preparation for residue analysis.
Aluminium oxide (89) and gel permeation chromatography (GPC) (90) or a combination of the
two (91-93) can be used to remove lipids from the sample. Florisil (48,90,94) and silica gel
(7,89,95) can be used for further fractionation of the extract. Reversed-phase chromatography
(C8 & C18) can also be used to isolate B[12012]-(202) and B[12012]-(212) from
environmental samples.
Silica gel pre-separation can be used to obtain a separation of technical toxaphene over
a wide range (68). In that reference it is also mentioned that B[12012]-(202) can be detected
free from co-eluting compounds after the pre-separation. The elution order of individual
chlorinated bornane congeners on silica gel is: B[12012]-(202) << B[21020]-(022) <
B[12012]-(212) << B[20030]-(122) < B[12012]-(112) << B[21020]-(122) < B[30030]-(122)
<< B[32012]-(111) << B[30012]-(211) + B[30012]-(121) << B[30030]-(111) (96). The
elution order of several individual toxaphene congeners on reversed phase HPLC was recently
presented (97).
When a silica fractionation is used individual congeners should be used to establish the
volume range of the toxaphene fractions and to evaluate recoveries, low recoveries for certain
congeners may occur when only a technical mixture is used for optimisation (69,98). De B er
et al. (69) used columns of 2.5 g SiO2.2% H2O (w/w), the bulk of the toxaphene compounds,
including the most relevant congeners were eluted in a second fraction of 12 ml diethyl
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ether/iso-octane (20:80, v/v) after a first fraction of 13 ml iso-octane which contained most
PCBs. Only 1-2% PCBs were present in the toxaphene fraction, which did not seriously
interfere with the toxaphene quantification using ECD. The entire clean-up procedure resulted
in recoveries of 80-96% for total toxaphene, 84-100% for B[30012]-(111), B[12012]-(212)
and B[30030]-(122). B[12012]-(202) was divided over the two fractions (about 40% in the
first fraction and 60% in the second fraction) with an overall recovery of 85-95%. In a
collaborative study for the determination of four bornane congeners in fish oil, gel permeation
was used followed by adsorption chromatography on silica gel (99). This silica gel clean-up
was carried out using 1.0 g silica deactivated with 1.5% water. The toxaphene compounds
were collected together with PCBs and some organochlorine pesticides in the first fraction
eluted with 8 ml hexane/toluene (65:35 v/v). Although the results of this study were obtained
using GC-ECD, the recoveries were 77 to 100%, and the relative standard deviations of
reproducibility were 18±4, 24±5, 29±19 and 21±5 % for B[12012]-(202), B[12012-(212),
B[30030]-(122) and B[30012]-(111), respectively. Some participants would have preferred a
clean-up in which the toxaphene compounds and PCBs are separated as was done by Alder
and Vieth (92). They eluted the silica column before the hexane/toluene fraction with 8 ml
hexane in which the PCBs and p,p’-DDE were recovered. Some chlordane/nonachlor and p,p’-
DDT and B[12012]-(202) were also found in that fraction. Krock et al. (96) improved this
method by using 8.0 g activated silica. The sample is eluted with 48 ml of hexane to remove
PCBs followed by 50 ml hexane/toluene (65:35, v/v) in which the toxaphene compounds were
recovered.
Injection
Alder et al. state that the injector temperature should not exceed 513 K because severe
decomposition of compounds may take place (100). Bartha et al. (101) recommend an injector
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temperature below 523 K. It should be mentioned here that care should be taken with active
sites in the liner and the injector. Since there is a large variability of injector geometry it is
recommended to verify the optimal temperature by a series of simple tests. Alawi et al. (102)
showed that the response factors using splitless injection are lower than those using on-column
injection.
Bartha et al. (101) reported the use of pressure pulse injection (PPI) at 498 K, which
resulted in response factors 4 times higher than those obtained with splitless injection. This was
especially significant for compounds with a low vapour pressure and long retention times (e.g.
B[30030]-(122)) (101). Using this technique, the residence time of the compounds in the
injector is short and, therefore, the chance of degradation within it smaller.
Gas chromatographic separation
Table 5 gives the elution order of toxaphene compounds on various stationary phases. The
relative non-polar stationary phase, 5% diphenyl, 95% dimethylpolysiloxane (DB-5, Sil-8,
Ultra-2) column with lengths of 30 to 60 m and diameters of 0.15 to 0.32 mm I.D. is most
frequently used. However, more polar columns are often used to validate the results e.g., 14%
cyanopropylphenyl 86% dimethylpolysiloxaan (DB-1701, Sil-19) (107), 6%
cyanopropylphenyl 94% dimethylpolysiloxaan (DB-1301) (99).
Krock et al. obtained a relatively good separation using a very non-polar Sil-2
stationary phase (comparable to squalene) (96), th  same elution order as on the more polar
DB-5 columns was found (103). The CP-Sil 2 phase was successfully used up to a temperature
as high as 563 K, although the supplier advised a maximum temperature of 473 K. No
alteration of retention times was observed after several hundred analysis on this phase (101).
By comparing the retention times of B[12012]-(20 ) with B[12012]-(112) and B[30030]-
(022) with B[30030]-(112) it was suggested that compounds with one chlorine on both C8 and
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C9 elute much later from this phase than compounds with two chlorines on one of these
carbons. Furthermore, by comparing B[12012]-(202) with B[03003]-(202) and B[12012]-
(112) with B[30030]-(112), it was found that compounds with a alternating endo-exo
substitution elute earlier than compounds with two chlorines at both C2 and C5 (103).
Nikiforov et al. (106) split the bornane skeleton into two parts, the six-membered ring
‘Ring’ and the three methyl groups ‘Metil’. By comparing available retention indices (RI) to
those from a DB-5 type phase with the substitution of these two parts of the molecule, several
correlations were found and the following conclusions were drawn:
1. The RI of compounds with either the same Ring or Metil increases with the degree of
chlorination of the other.
2. For all Metil substitutions the RI increases with the following Ring substitution: [12012] <
[30012] < [30030] < [21022].
3. For all Ring substitutions the RI increases with the following Metil substitution: (202) <
(112) and (211) < (112).
The use of heart-cut multidimensional gas chromatography (MDGC) (108) offers a
possibility to overcome co-elution problems due to the large amount of congeners. By
transferring heart-cuts from a separation performed on a DB-5 type phase to a 15%
dimethylsilicone, 85% polyethylene glycol (DX-4) phase, in addition to a polyethylene glycol
terephthalic acid ester (FFAP and a 10% cyanopropyl, 90% biscyanopropyl polysiloxane (Rtx-
2330) phase for further separation (a multidimensional set-up) (69), it was observed that a
large number of peaks were to be found in the secondary chromatograms indicating that the
resolution offered by one single column is insufficient and can easily lead to false-positive
results, especially when the non-selective ECD is used for quantification. There were no large
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differences between the column combinations but the DB-5 - Rtx-2330 combination was
preferred because of its somewhat better separation but mainly because of its low bleed.
However, Baycan-Keller and Oehme (109) found degradation of B[32012]-(111), B[30012]-
(211), B[30012]-(121), B[30012]-(212), B[30030]-(122), B[12012]-(212), B[32030]-(112)
on the Rtx-2330 phase. Re-evaluation of the multidimensional heart-cut data of de Boer et al.
(69) showed that the standard of B[12012]-(212) has the same profile (a broad hump eluting
together with the analyte peak) as described by Baycan-Keller and Oehme, and indeed this
could have been caused by decomposition on the stationary phase. However, for B[12012]-
(202), B[30012]-(111) and B[30030]-(122) normal peak shapes were obtained. Karlsson and
Oehme also mention that there is a possibility that the low response of B[30030]-(122) is due
to losses on the polar Rtx-2330 phase (107).
Alder et al.found that B[12012]-(202) and B[30030]-(122) were decomposed to a
great extent on the highly polar DX-4 phase (100). In the study of de Boer et al. (69)
degradation effects were not observed on this phase, this was also evident after re-evaluation
of data and further experiments with this stationary phase (Figure 3). This can, at least partly,
be due to the fact that a shorter column was used (15 m instead of 30 m) which limits the
exposure time of the components to a high temperature, which was 493 K.
It is extremely time consuming to analyse several compounds in a complex sample
using a multidimensional set-up, even when a system with several parallel traps for storage of
heart-cuts is available (108). If the speed of the secondary separation is high enough to
separate a cut from the first dimension, while the next cut is being collected, it will then be
possible to record a connecting set of secondary chromatograms. From the secondary
chromatograms the complete two-dimensional chromatogram can be constructed, much like
thin layer chromatography. A method capable of doing this is called ‘comprehensive’ (110). A
comprehensive separation uses the whole two-dimensional separation space to generate
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resolution, provided that the individual separations are based on different interactions (are not
correlated). For a method to be comprehensive it is necessary that the first dimension is
sampled at least every peak width by the second one. The first dimension can then be
constructed from the secondary chromatograms (111,112). Research to make this powerful
separation technique available for toxaphene analysis is currently under investigation.
Detection
The use of MS detection would overcome some of the problems of co-elution, in addition to
those caused by compound class or the degree of congener chlorination. In the electron impact
(EI) mode co-elution with compounds having similar fragmentation patterns may well occur
and will lead to false positive results. Structural information is of course much more limited in
the NCI mode. The ECD is an attractive alternative detector, however, since ECD is less
selective than MS detection, an even more efficient separation will be necessary.
Flame ionisation detection of toxaphene shows little difference to the profiles obtained
with full scan EI/MS and has a low response dependency on the chlorine substitution pattern,
however, only the latter technique has the selectivity and sensitivity necessary for residual
analysis (92). NCI/MS shows a completely different peak profile, which is probably caused by
the higher variation in response factors for individual congeners (11).
When using the ECD, removal of interfering compounds is a prerequisite. PCBs, for
example, are present at high concentrations in most environmental samples which may also
contain toxaphene compounds. In addition, PCBs have higher response factors due to their
aromatic character. Andrews et al. (113) used high resolution MS in the selected ion
monitoring (SIM) mode at m/z 158.8768 and 160.9739 with EI as ionisation method to obtain
a total chlorinated bornane result without interference from other compounds. However, this
approach is less sensitive than the NCI mode and it does not distinguish between homologue
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groups. NCI offers both selectivity and sensitivity for bornane congeners (114), but does not
offer the possibility of structure elucidation.
NCI is most widely used MS detection method for toxaphene, but is insensitive to
lower chlorinated congeners. The EI mode is relatively more sensitive to lower chlorinated
congeners and, consequently, an additional 25 peaks from lower chlorinated compounds were
found with EI compared to NCI (68). Often both the M- and (M-Cl)- ions are monitored
(67,101). Problems with GC-NCI/MS in the SIM mode include the formation of (M-OCl)-
fragments of PCBs, false positive signals may, in part, be caused by chlordanes and the
appearance of higher chlorinated bornane congeners (67,73,115). Krock et al. do not observe
the interfering oxygen adducts of PCBs, which have only been reported to occur when small
leakages are present in the MS (96). Good linearity over four orders of magnitude for five
chlorinated bornane congeners was obtained using NCI/MS (102). It was tentatively found
that a 2,2,5,5-substitution of chlorobornane congeners ([30030]) had a negative effect on the
NCI/MS response (81,116).
Buser and Müller used tandem MS/MS with EI to identify B[12012]-(202) and
B[12012]-(202) in penguin and harbour seal samples (15). Most toxaphene congeners produce
fragments with m/z = 125 under EI conditions, this ion, together with ions at m/z = 159, 195
and 231, are considered to be characteristic of toxaphene congeners (62). In co trast with
quadrupole or double focussing MS/MS, in which tandem mass spectrometry is accomplished
through space, Saturn 4D MS/MS uses the time dimension to accomplish MS/MS. The
isolation of precursor ions and further dissociation takes place in the same chamber (m/z
locking), but at a different time. This reduces loss of precursor ions and hence provides better
sensitivity. The major ion in the daughter spectrum of m/z = 159 is a fragment at m/z = 125.
However, PCBs and some organochlorine compounds also produce this in the MS/MS mode.
Therefore, the ion at m/z = 89 (dechlorinated monochlorotropylium ion), which orginates from
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the m/z =125 ion, would be more useful for quantification of toxaphene congeners (117).
However, co-elution of compounds which produce this ion cannot be observed. Furthermore,
the response factors with this method will vary considerably for individual cogeners
((B[12012-(202) 2.3; B[30012]-(111) 3.2; B[12012]-(212) 0.7; B[30030]-(122) 0.7; technical
mixture 1.7)). The authors suggest that the fact that their results were all lower than the
average results in a round robin test in which they took part (98) could be explained by the
specificity of their method.
Alder and Vieth (92) determined the toxaphene concentration in a standard reference
sample (SRM 1588) on the basis of three indicator congeners using GC-ECD. They found a
total toxaphene concentration of about 1600 µg kg-1. In contrast with this result, Fowler et al.
(118) determined a value of 5410 µg kg-1 in the same sample using GC-NCI/MS. Alder and
Vieth reanalysed the sample then using NCI/MS and found a value of 5210 µg kg-1, which is
close to the value reported by Fowler et al. They concluded that this large difference is caused
by the large difference in response factors between congeners with NCI which gives a positive
bias to the results when compared with ECD which has a smaller difference between response
factors. Rantio et al. (48) also showed that NCI/MS gave in general higher results than ECD.
However, the results showed a linear relationship between the two detection techniques, which
made it possible to compare the obtained results. The higher response of NCI/MS was also
reported by Wideqvist et al. (46), especially when the degree of chlorination is higher. In
contrast with this, Xu et al. (119) found that GC-ECD gave identical results to GC-NCI/MS
for the quantification of individual chlorobornanes in fish samples. A possible explanation for
these, at first view, contradictory observations could be the use of different standards in
combination with the detector used, which can influence the end result to a large extend, as
was shown by Carlin and Hoffman (86). For example, with one standard the same result for
GC-ECD and GC-NCI/MS can be obtained while with another largely differing results can be
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found. Another explanation can be differences between the MS configuration used in the
studies.
ECD determination of total toxaphene has insufficient selectivity, while NCI/MS
suffers from variable response factors. To obtain precise and comparable data the use of
indicator compounds as a basis for calculation of total concentration was advised (92).
However, this approach can only successfully be used when the indicator compounds do not
co-elute with other compounds. Co-elution of suggested indicator compounds was shown by
heart-cut multidimensional gas chromatography (69). Depending on the sample type, up to ten
peaks were found when the analyte peak was further separated on a second, different column.
For B[12012]-(202) and B[30030]-(122) the area fraction of the compound in its first
dimensional peak was between 20 and 85%, while that of B[12012]-(212) was 85 to 95%.
Therefore, only B[12012]-(212) can reliably be determined after a one-dimensional separation.
However, it must be noted that most samples analysed were from organisms placed relatively
high in the food chain.
Enantiomers
Usually, enantiomer ratios (ERs) are used to express the ratio in which the enantiomers are
present. The peak area/height of the (+)-enantiomer is divided by that of the (-)-enantiomer
(120-123). When the conformation of the enantiomers eluting from a chromatographic system
is not known, as with enantiomers present in toxaphene, the ER is often expressed as the peak
area/height of the first eluting enantiomer divided by that of the second (124). U ing the
quotient of the two enantiomers gives an undefined result when the second enantiomer is not
detected. De Geus et al. (125) observed this and, therefore, divided the second enantiomer by
the first. Of course, this approach only shifts the problem. It would be better to divide by the
detection limit (which does not equals zero) when a compound is not found, but this can lead
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to very high or low numbers. In addition, due to the reciprocal-like scale, ERs larger than unity
‘seem’ to deviate more than ERs smaller than unity (e.g. 6.7 and 5.0 vs 0.15 and 0.20). To
avoid these disadvantages the (+)-enantiomer or the first eluting enantiomer can be expressed
proportional to the sum of the two (126). This enantiomer fraction (EF) is 50% if both
enantiomers have the same abundance. The advantages of using EFs are an understandable
linear scale, dividing by zero or very high and low values do not occur and similar enantiomer
proportions are distinguished easier. Deviations from the racemic value have the same
magnitude in both directions.
Most of the compounds in toxaphene are chiral. Since bioaccumulation and metabolism
in biota are often different for enantiomers, a change in the EF can be expected during
disposition in the food chain. Furthermore, enantiomers often have different toxic properties.
The determination of EFs in biota can give an indication whether a specific biological
mechanism changes the ratio in the course of disposition in the body. A significant deviation
from the EF value present in the technical mixture, (usually 50%), suggests a specific
metabolic transformation of one of the enantiomers. On the other hand, an equal EF points to
biological persistence (124). The comparison of the EFs of different congeners in combination
with their molecular structures can help to gain an insight into the metabolism of these
compounds.
When determining EFs of chlorinated bornanes in biota, it cannot be excluded that the
values found are not merely due to metabolism in the species studied, since a change during
previous disposition in the food chain is also possible. Feeding studies in which the species of
interest is exposed to (racemic) mixtures of known composition will eliminate this problem. As
an alternative, in vitro assays can be used in which microsomes are incubated with the
compounds of interest. The microsomes contain the cytochrome P-450 dependent mono-
oxygenase enzyme systems which are involved in enantioselective and non-enantioselective
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biotransformation. Boon et al. (127,128) successfully used such an approach to study the
achiral biotransformation of toxaphene congeners by microsomes from harbour seal,
whitebeaked dolphin, sperm whale and laysan albatross.
For the determination of EFs the separation should be enantioselective as well as
isomer-specific, unfortunately, this doubles the number of peaks that have to be separated
(125). A tert.-butyldimethylsilylated ß-cyclodextrin phase, introduced by Blum and Aichholz
(129), has been shown to give a good enantiomer separation of toxaphene compounds
(15,104,124,125,130). However, the enantiomer separation of bornane congeners is still a
rather empirical task and the selection of a convenient stationary phase is primarily determined
by trial and error (131). It has been shown that columns based on heptakis(2,3,6-O-
tert.butyldimethylsilyl)-ß-cyclodextrins (TBDM-CD) are especially suitable for the separation
of polychlorinated bornane enantiomers (15,124,132,133). Unfortunately, this stationary phase
is not very well defined and batch-to-batch differences have been observed (134). Vett  t al.
(135) compares several enantioselective phases for the separation of toxaphene compounds.
The obtainable enantiomer resolution is dependent on the column oven temperature
profile. It was found that this phase can be used up to a temperature of 535 K in a
programmed run. However, at lower temperatures the obtained resolution is much higher
(130). Baycan-Keller and Oehme (104) showed that a temperature ramp of 1 K resulted in
much better separations compared to 10 K. This was also found by De Geus et al. (125),
unfortunately, slow temperature programs lead to very long run times which can be a problem
when compounds with a low concentration have to be detected.
Most attention has been devoted to measuring the EFs of B[12012]-(202) and
B[12012]-(212) (Table 6) (15,137). However, studies by Vetter et al. (130) and De Geus et al.
(125) show that other compounds can be much more interesting because they show more
enantioselective activity (Table 7).
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Parlar et al. (139) states that all parent compounds in toxaphene occur as racemates.
Buser and Müller showed that some compounds are present in the technical formulation
(Melipax) in non-racemic compositions (140). However, interferences from other compounds
cannot be excluded, even in the MS/MS method they used. Vetter et al. (130) isola ed the
compound B[21020]-(022) from Melipax. The mass spectrum of this compound showed no
significant impurities, however, the first eluting enantiomer was significantly more abundant
than the second. The EF was 55.8±0.6%. Furthermore, the authors showed that the EF of this
compound was 50.0% in a cod liver extract from the Baltic. When a synthesised standard with
a racemic composition would have been used, the conclusion that no enantioselective process
has taken place might be drawn, which shows the importance of carefully choosing the
standard. On the other hand deviation of this compound from the racemic value should also be
shown in other technical formulations since Melipax accounts for only 5% of the global
toxaphene production (141) and B[21020]-(022) and the contribution of B[21020]-(022) to
Melipax is <1% (130).
Parlar et al. (139) present EFs of several chlorinated bornanes in Cod liver oil, Herring,
Halibut, Caviar and Redfish samples obtained from Refs. (107,124,136). The EFs show little
variation; 50.2±1.2% and therefore, Parlar et al conclude that no significant degradation of
toxaphene enantiomers takes place in fish. Unfortunately, the Refs. (124,136). present other
EFs (Table 6) and Ref. (107). does not present EFs. The data in Table 6 are only for
B[12012]-(202) and B[12012]-(212), the mean EF is 53.1±2.7%, which is not a large
deviation from the racemic value. In a recent study (138), Parlar et al. show that B[20030]-
(122) and B[30030]-(122) show EFs deviating from the racemic value in cod liver oil and fish
oil (Table 7). B[12012]-(202) and B[12012]-(212) have EFs closely around the racemic value,
but in one cod liver oil sample a deviating value is found for B[12012]-(202), 58.5%. That
sample is subject to further study.
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The results of Alder et al. (136) show that the EF value of these compounds in warm-
blooded species (human milk and cynomologus monkey adipose) deviate from unity. This is in
accordance with the observed EF of 57.3% for B[12012]-(212) in Antarctic penguins by Buser
and Müller (140). This could indicate a more efficient metabolism present in these species
compared to other species (fish).
Interlaboratory study.
A German collaborative study with a contaminated milk fat undertaken in the mid eighties
demonstrated the analytical difficulties and uncertainties in the analysis of technical (total)
toxaphene by packed column GC-ECD (142). Andrews found that in many laboratories only
about 15-30% of toxaphene components were eluted from silica or Florisil columns with a
non-polar solvent. This was thought to be the main source of the large variation between labs
(98). In a German inter-calibration experiment recoveries of 77 to 100% with a relative
standard deviation of reproducibility of 23 (9.2-50.5)% were found for four indicator
compounds in a fatty matrix. On the basis of these results the method was recommended for
routine analysis in food inspection in Germany (99). I  a recent QUASIMEME laboratory
performance study with four toxaphene congeners in standard solutions most of the 15
participants reported satisfactory results (143).
Indicator compounds
Ideally, toxicity should play a major role in the selection of indicator compounds.
Unfortunately, at present little is known about acute and chronic toxicity of individual
congeners to mammals. Occurrence determines, in combination with toxicity, whether a
compound is important or not. Stereochemistry may play an important role since the biological
disposition of enantiomers varies (Ref. (125) and Table 7). Boon et al. (128) showed that
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B[12012]-(202) and B[12012]-(212) did not give a positive response in a mutatox test, while
technical toxaphene and B[30012]-(111) did. The latter compound is only detected in low
concentrations in wildlife samples (69,99,117).
Next to these parameters the analytical convenience is important. The compounds
should be detectable without the interference of other compounds when common extraction,
clean-up and separation/detection procedures are used. The compounds should also be
commercially available (92).
In practice, the availability of standards and the analytical convenience dictate the
choice of compounds, a situation similar with that of PCBs. The concentrations of B[12012]-
(202), B[12012]-(212) and B[30030]-(122) are in the 0.05 - 0.08 mg kg-1 (fat basis) range in
fish and other foodstuffs and their peaks represent about 50% of the total toxaphene ECD
response. Because it is presumed that these congeners are also dominant in human toxaphene
intake, Alder and Vieth (92) suggested to use them as indicator compounds. To be able to
distinguish between recent contamination (e.g., recent use of the pesticide) or from persistent
congeners still present in the environment), an indicator compound can be included which is
not stable in the environment. B[30012]-(111) was suggested for this purpose (92). Xu et al.
(119) proposed a second compound B[30032]-(122) for the same purpose. This compound
was found to degrade easily in the detector, and is only present in minor amounts in technical
formulations, therefore, it is not very useful as indicator compound (92). Measuring the
individual indicator compounds on a single GC-column has the problem that several
compounds may be present in one peak as was shown by heart-cut multidimensional GC (69).
Instead of measuring the toxaphene compounds in all fish for consumpti n, samples
from important species and fishing areas can be selected to answer the question of human
intake of these compounds as was done in a large study by Alder et al. (100). As an ternative,
Alder and Vieth (92) chose to mix edible parts of relevant fish samples (97), before extraction
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and residue analysis. The fish samples however, were not prepared in the way they are
generally consumed.
LEVELS IN BIOTA
Total toxaphene
Most of the available information about toxaphene concentrations in biota is referred to in
terms of total toxaphene. However, since the number and pattern of congeners in
environmental samples is substantially different from the technical mixture (as a result of
environmental and metabolic modification) ( e.g., 88,113), values for total toxaphene should
only be considered indicative. Table 8 gives an overview of the total toxaphene levels in biota
samples as reported in the literature.
Much of the information about total toxaphene levels in biota described in literature
are from freshwater systems in Canada and the U.S.A. where it was one of the most dominant
organochlorine residues (161). Toxaphene concentrations plateaued after a period of steady
increase through the 1970’s, but its incidence continued to increase: residues were present at
88% of the stations sampled in 1980-81 (162). In 1978-79, toxaphene concentrations were
highest in lake trout (Salvelinus namaycush) samples from Lakes Michigan and Superior with
typical concentrations of 5-10 µg g-1 lipid (163). In 1980-81 concentrations were generally
lower, 2-5 µg g-1 lipid. Concentrations of toxaphene declined in trout and smelt from the
Great Lakes between 1982 and 1992, with the exeption of fish from Lake Superior (159).
Little toxaphene has been used in the Great Lakes basin itself, the main input is
thought to be through atmospheric transport from the southern US or Central America,
followed by wet and dry deposition (53,115). Atmospheric transport was probably also
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responsible for residues detected in fish from lakes in Alaska. Several other reports conclude
that toxaphene is carried through the atmosphere from the site of application and its
accumulation is widespread in freshwater and marine fish (e.g., 90).
Geographic variation in toxaphene and other organochlorine pesticides within the
Canadian Arctic has been examined in several studies. In Arctic char (Salvelinus alpinus)
residues of toxaphene generally increased from west to east, with generally higher levels in
samples from Baffin Island and Hudson Bay (164). The results for Arctic char are consistent
with the movement of organochlorines in air masses from south/central America in a
northeasterly direction. Declines in concentrations of several organochlorines were also found
for burbot (Lota lota) along with increasing northern latitude (155). Toxaphene was the
predominant organochlorine residue in northern fish samples. The peak pattern of toxaphene
in the chromatograms showed extensive transformation compared to technical toxaphene
mixtures. Levels of toxaphene were not significantly correlated with age or weight of the fish.
Kidd et al. (156) studied the spatial variability of toxaphene in fish from lakes in the Yukon
Territory which were collected between 1990-92 and found that the levels varied considerably
between lakes probably due to differences in the food chains of the lakes.
Toxaphene was also the major organochlorine residue in Canadian Arctic marine
invertebrates and fish. Arctic cod (Boreogadus saida) in three eastern Arctic locations had
concentrations five- to ten-fold higher than for DDT or PCB (146). Musial and Uthe (84)
found that levels of CHBs in Arctic cod liver were about two-fold lower than those of Atlantic
cod (Gadus morhua). Bidleman et al. (2) reported levels of toxaphene to be equivalent to
PCBs in zooplankton and in amphipodes collected from an ice island in the Arctic Ocean.
Other organochlorines had lower concentrations. Toxaphene was found to be a major
contaminant in Atlantic cod liver and herring (Clupea harengus) muscle from eastern
Canadian waters with levels similar (lipid wt basis) to PCB but generally higher than DDT
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(84). Toxaphene was not detected in deep-sea (Canadian waters) scallop (Placopecten
magellianicus) (84).
High levels of toxaphene have been reported for white-beaked dolphins
(Lagenorhynchus albirostris) and pilot whales (Globicephala malaene) collected during
1980-82 from the coast of Newfoundland (152). This was explained with the increased use of
toxaphene during the 1970s. Toxaphene levels were higher than for other organochlorines
measured (PCB, DDT, etc.). The majority of the peaks in the toxaphene standard were not
present in dolphin blubber, indicating considerable metabolism and/or selective accumulation
of some isomers and/or metabolites. Two peaks accounted for about 50% of the toxaphene
peaks (probably GC-EI/MS). Toxaphene was the major organochlorine contaminant detected
in blubber of Arctic belugas (Delphinapterus leucas) (150). Little geographic variation in the
concentration of toxaphene was observed in five different areas (E. Hudson Bay, Cumberland
Sound, W. Hudson Bay, Beaufort See and Jones Sound). Geographic comparisons of
toxaphene levels for belugas are difficult because they migrate over relatively long distances
and spend most of the year at the ice edge rather than at the locations were they were
sampled. Belugas collected from north coast of Alaska contained higher toxaphene
concentrations in blubber (151), than for PCBs, DDTs and chlordanes in the same samples.
Males had higher concentrations than the females and the oldest male had a higher
concentration than the younger male. Transplacental transfer to the foetus in addition to
lactation is the most probable cause of the lower levels in females compared to males. Stern et
al. (165) identified the two major recalcitrant toxaphene congeners in aquatic biota from
beluga blubber; B[12012]-(202) and B[12012]-(212). Their sum constituted 28-34% of total
toxaphene in arctic char, 53% in burbot and 81-89% in beluga whale blubber from Canadian
Arctic.
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Toxaphene were the dominating organochlorines in narwal (Monodon monoseros)
collected 1982-83 from northern Baffin Island in the Canadian Arctic (94),. The toxaphene
consisted of two major components, an octachloro- and a nonachlorobornane. The pattern of
organochlorines in narwal tissue suggests they are exposed to proportionally more volatile
compounds, and may have a lesser capacity to metabolize some of these compounds, relative
to odontocetes living closer to sources of these contaminants.
Toxaphene was measured in landlocked Arctic char and ringed seal (Phoca hispida)
from Greenland (145). The char showed levels that were significantly higher on the east coast
compared to areas of the west coast, however overall the levels of toxaphene in muscle were
low. Seals displayed no significant geographical variance, presumably due to relatively high
biotransformation capacity for toxaphene (128).
Zell and Ballschmiter (4) analysed fish from different regions to characterize
organohalogens in pristine aquatic environments. They found toxaphene in spawn of Arctic
char (Salvelinus alpinus) from a lake in the Tyrolian Alps, pike (Esox lucius) from northwest
Ireland, sturgeon (Acispenser stellatus) from the Caspian Sea, salmon (Salmo salar) from
Ireland and Alaska, and Antarctic cod (Dissostichus eleginoides) (liver) from South Georgia.
They indicated that the global pollution by toxaphene could be as important or even outrange
the global spreading of compounds like the DDT and the PCB-group. The pattern of
toxaphene was modified to a variable extent compared to that of technical mixtures. The
samples from the North Atlantic Ocean and the Caspian Sea contained about 10-fold higher
levels compared to samples from the other areas.
Few investigations of toxaphene in biota have been carried out in the lakes of Asia.
Kucklick et al. (26) studied organochlorines in the food chain of Lake Baikal in central
Siberia. Baikal seals (Phoca siberica) occupy the top trophic level feeding primarily on the
endemic whitefish or omul (Coregonus autumnalis) and planktivorous sculpin (Comephorus
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dybowskii). Toxaphene in biota ranged from 1.1 - 2.3 µg g-1 lipid in sculpin and seal
respectively, indicating little fish to seal biomagnification of toxaphene. The toxaphene pattern
in the seal was degraded to a greater extent relative to the fish but retained several prominent
congeners. These results are in agreement with degradation studies by Boon et al. (128).
The levels of toxaphene and other organochlorine pesticides have been analysed in
tilapia (Sarotherodon mossambicus) and guapote (Cichlasoma manag‚ense) collected in 1991
from Lake Xolotlán in Nicaragua (157). The carnivorous tilapia contained 4-5 higher
toxaphene concentrations than the omnivorousguapote. Location of a factory on the shore
producing toxaphene may have played a role for some of the relatively high values found.
Jansson et al. (149) reported total toxaphene residues in Arctic Char (Salvelinus
fontinalis) from lake Vättern in southern Sweden, and grey seal (Halichoerus gryphus) and
herring (Clupea harengus) from the Baltic Sea. The fish from the different areas gave similar
chromatograms indicating a widespread input to the whole region via the atmosphere. This
was supported by Paasivirta and Rantio (166) which compared toxaphene levels in salmon
from the Arctic and the Baltic and found no significant difference. Similarly, levels of
toxaphene in cod liver did not differ. Toxaphene has not been used as pesticide in Scandinavia.
Andersson and Wartanian (72) analysed toxaphene in blubber samples from different seal
species collected from the Baltic and the west coast of Sweden. Toxaphene levels in Baltic
seals were higher than those found in animals on the west coast of Sweden. Comparison of the
data for adult and juvenile seals showed one major species dependant in addition to an age-
related variation in contamination, i.e. the toxaphene levels in adult Baltic ringed seal were
significantly higher compared to the adult grey seal from the same region, and 5-10 times
higher than in juvenile ringed seal from the same region. Andersson et al. (148) repor ed no
geographical differences in concentrations of toxaphene from animals in the Arctic region with
corresponding species in the Baltic.
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Several reports on levels of toxaphene in fish and fish products from Europe show the
ubiquitous presence in all types of fish (e.g., 89,167,168). High residues of toxaphene in fish
and fish products from Europe was reported by Müller et al. (167) showing that toxaphene
concentrations in herring and mackerel (Scomber scombrus) from the North Sea and the
relatively remote waters west and northwest and of Ireland and Shetland Islands exceeded the
German tolerance level (which was 0.1 mg kg-1 on lipid basis or 0.01 mg kg-1 w.w. at that
time). Van der Valk and Wester (89) carried out a study in fish from northern Europe. The
highest toxaphene concentrations were found in herring oil from the Baltic (7 µg g-1 lipid).
Toxaphene in cod liver showed an upward trend from southern to northern North Sea,
increasing from 0.4 to 1 µg g-1 lipid. This was somewhat unexpected since the northern North
Sea usually is considered less polluted than southern North Sea. De Boer and Wester (7) state
that in Western Europe toxaphene has practically never been used. Accumulation of toxaphene
in North Eastern Atlantic waters may be brought about by aerial transport from the American
continent. They also reported that Baltic herring oil contained a high toxaphene concentration
probably due to the continued use of toxaphene in the East European countries.
Concentrations of individual congeners
Gooch and Matsumura (158) suggested that since the environmentally derived toxaphene is
extensively altered in comparison to the technical material, measurements of only the toxic
congeners would be environmentally relevant. They reported mean levels of Toxicant A (a
mixture of B[30030]-(211) and B[30030]-(121)) and B[30012]-(111) in the fish were 0.26
and 0.1 µg g-1 w.w., respectively, approximately one order of magnitude less than the
estimated concentration of total toxaphene.
Hainzl et al. (88) analysed individual toxaphene compounds in fish and caviar from
several European countries. B[30012]-(111), B[12012]-(212) and B[30030]-(122) were the
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most prominent compounds while B[12012]-(202) and B[30032]-(122) were below detection
or at very low concentrations (<0.1 ng g-1) in all samples analysed (Table 9). Icelandic cod
liver contained the highest concentrations (Table 9). Toxaphene in hake liver from west of
Ireland, herring muscle and dolphin blubber from the North Sea were all studied by de Boer et
al. (170) who found that B[12012]-(202) and B[12012]-(212) were dominant compounds
while B[30012]-(111) was not detected in most samples.
Alawi et al. (102) analysed B[30012]-(111), B[12012]-(212), B[30030]-(122),
B[12012]-(202) and B[30032]-(122) in samples of marine fish by different analytical
techniques. The fish and fish products were obtained from Iceland, Greenland, Japan, Norway
and Germany. The compounds B[12012]-(202), B[12012]-(212) and B[30030]-(122) were
present at concentrations similar to important PCB congeners and cyclodiene insecticides in
most of the fish samples, especially from the North Atlantic. These three chlorinated bornanes
constituted the major portion of the toxaphene residues in cod liver oil (25-30%). In fresh fish
and caviar these substances amount to approximately 8-12% of total toxaphene. B[30012]-
(111) was found in only a few samples and at very low concentrations. B[30032]-(122) was
below detection in all samples analysed. Cod liver oil and salmon oil from the North Atlantic
contained higher levels of toxaphene than red fish and halibut (Table 9).
Alder et al. (100,136) analysed three indicator compounds (B[12012]-(202),
B[12012]-(212) and B[30030]-(122)) in different samples of fish from the North Atlantic
Ocean, North Sea, Baltic Sea and a few other locations (Table 9). Highest residue
concentrations were found in marine fish with moderate to high fat content, e.g. halibut,
herring, redfish and mackerel. The sum of the indicator compounds in sardines and in fish with
lean muscle tissue (Alaska pollock, saithe, hake and cod) levels were low. Farmed salmon
from Chile showed lower levels of the three compounds than salmon from the northern
hemisphere. Eel from the Baltic contained relatively low levels. Fromberg et al. (171)
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determined the three indicator compounds in several fish samples from Danish waters. Their
concentrations ranged from ca. 5 - 50 ng g-1 fat and are in agreement with previously reported
results for mackerel, eel, salmon and herring from Skagerak, whereas they are 3-8 times those
that were reported for herring from the Baltic Sea (100). However, fish, especially herring are
not stationary and differences might be influenced by migration.
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Conclusion
The literature shows that toxaphene has a global distribution and can be found in both fresh
water and marine biota all over the world. Also at remote areas at long distance from the
sources the levels in biota can be quite high. This illustrates the importance of long range
transport probably through the atmosphere for this group of contaminants.
TOXICOLOGY
Since the late 1940s, reports have been published addressing the toxicity of the chlorinated
camphenes to fish, birds, and mammals (172-176). In addition, toxaphene was found to elicit
mutagenic and carcinogenic properties in mammalian test systems and hence pose a treat to
human (25,177).
Toxicokinetics and biotransformation
The use of toxaphene as a piscicide was discontinued after the discovery that toxaphene was
persistent in the aquatic environment and prevented successful re-stocking of treated lakes
with desirable fish (178,179). However, experimental information on the depuration of
toxaphene in fish and their residue kinetics is scarce. Delorme et al. (180) studied the
elimination rate of toxaphene and two of the more persistent congeners, B[12012]-(202) and
B[12012]-(212) in lake trout and white suckers in a natural ecosystem following intra
peritoneal (i.p.) injection of technical toxaphene (7 µg g-1 for white suckers and 3.5 and 7 µg g-
1 for lake trout). The estimated half-lives for total toxaphene were found to be 524 days in
white suckers and 232 (high dose) and 322 (low dose) days in lake trout. Half-lives for the two
congeners in trout were 294 and 376 days (high dose) and 316 and 367 days (low dose)
respectively. In white suckers, only B[12012]-(202) was detected and its half-live was 716
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days. From these results, the authors concluded that under natural living conditions these
species differ in elimination rates of toxaphene and that elimination of two different
chlorobornane components (B[12012]-(202) and B[12012]-(212)) of toxaphene is different
within a given species.
Mohammed et al. (181) studied the role of plasma lipoprotein in the transport and
tissue accumulation of toxaphene. 14C-radiolabeled toxaphene in the absence or presence of
either low density lipoproteins (LDL) or high density lipoproteins (HDL), was injected intra
venous (i.v.) into normo- and hypolipidemic mice. In normolipidemic mice, most of the
radioactivity was initially found in the liver and adrenals either in the absence or presence of
LDL or HDL. Four hours after application, the radioactivity was redistributed into the adipose
tissue. Notably, a lower amount of radioactivity was found after 20 min in mice injected with
toxaphene in combination with HDL compared to 14C-toxaphene-LDL injected mice,
suggesting a more efficient metabolism and disposal of toxaphene when HDL was used as
carrier. In hypolipidemic mice, Mohammed and co-workers initially found lesser label in the
liver and adrenals and more in the kidney and heart (181). 14C-toxaphene was redistributed
mainly to the liver and only in small amounts to adipose tissue 4 h after injection. According to
the authors, these results indicate that changes in the lipid pattern may influence the tissue
distribution of toxaphene. Mohammed et al. (181) lso studied the distribution of 14C-
radiolabeled toxaphene among lipoprotein fractions in vitro a d in vivo using human and rat
plasma. In rat 37-52% of radioactivity was recovered in the HDL fraction, while 18-52% was
associated to the albumin-rich bottom fraction (BF) both in vivo and in vitro. In contrast to
rat, the in vitro distribution of 14C-toxaphene among human lipoprotein fractions was shown to
be relatively homogenous. In the BF, 26% of radioactivity was found whereas in the HDL,
LDL and very low density lipoproteins (VLDL) fractions 27%, 29% and 18% of radioactivity
was recovered, respectively.
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Reductive dechlorination or dehydrochlorination and in some cases oxidation have
been shown to be the major mechanisms by which toxaphene is metabolised in microorganisms
as well as in insects, birds, aquatic organisms and mammals (1,182). Degradation of toxaphene
in the soil proceeds rather slowly under aerobic conditions whereas under anaerobic
conditions, toxaphene is more easily degraded (139). Fingerling et al. (36) investigated the
degradation of six polychlorinated bornanes (B[30012]-(111), B[30012]-(211), B[30012]-
(121), B[30012]-(112), B[30012]-(212) and B[30012]-(122)) isolated from technical
toxaphene as well as the technical mixture in a loamy silt under anaerobic conditions. All of the
individual bornanes were transformed by reductive dechlorination, generally starting with the
removal of a chlorine atom from the geminal dichlorogroup in the C-2 position. The
dechlorination rate was shown to depend on the chlorination stage (nonachlorobornanes >
octachlorobornanes > heptachlorobornanes). Two stable end-metabolites formed from all of
the six bornanes were isolated and identified as B[21002]-(111) and B[21001]-(111).
Interestingly, the major degradation product of technical toxaphene was shown to be
B[20012]-(111), one of the two end-metabolites of the six individual bornanes tested. In
addition, Fingerling et al. (36) showed that none of the components tested was degraded in
autoclaved soil, indicating that degradation is mediated primarily by microorganisms.
In contrast to the identification of dechlorination products formed from toxaphene
components as well as technical toxaphene under anaerobic conditions in soil, reports on the
isolation and characterisation of oxygen containing products is scarce. Fingerling and Parlar
(183) for the first time isolated and characterised an oxygen-containing product as conversion
product of the toxaphene components B[30012]-(211), B[30012]-(121), and B[30012]-(111)
under anaerobic conditions. This cyclo ketone (7b,8c,9c-trichlorocamphene-2-one) is most
probably not formed from one of the two main hexachlorobornane products (36), but possible
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formed from the dehydrochlorination product B[21001]-(111) which is formed as a small
byproduct from B[30012]-(111) as well as from B[30012]-(211) and B[30012]-(121).
As was reviewed by Saleh (1) hepatic microsomal mixed function oxidases play the
most important role in toxaphene metabolism in mammals, followed by glutathione-S-
transferases. Chandra and Durairaj (184) showed that in addition to induction of cytochrome
P-450 and aniline hydroxylase activity in the liver, toxaphene also induces these enzymes in the
kidney. Therefore, the authors speculate that toxaphene itself might be metabolised in the liver
as well as the kidney.
In an attempt to evaluate the role of phase I biotr nsformation in the bioaccumulation
process of toxaphene, Boon et al. (128) demonstrated in vitro metabolism of toxaphene using
hepatic microsomes from harbour seal, whitebeaked dolphin, harbour porpoise, and the
albatross sampled shortly after death. In addition to toxaphene, the in vitro m tabolism of four
individual chlorobornane congeners was tested. B[12012]-(202) and B[12012]-(212) were
persistent in all assays whereas B[30012]-(111) was metabolised by hepatic microsomes
isolated from the four wildlife species. It was also found that harbour seal hepatic microsomes
only metabolised B[30030]-(122). Neither toxaphene nor the four congeners were metabolised
in vitro using hepatic microsomes of the sperm whale. Interestingly, their results showed that
the in vitro capacity of microsomes derived from the different species to metabolise the
technical toxaphene, reflects the decreasing number of peaks in the toxaphene residues of
wildlife extracts.
Aquatic toxicity
Toxaphene is highly toxic for aquatic organisms. It was found that in general saltwater fish are
more sensitive to toxaphene then freshwater fish (mean acute toxicity values of 0.07 µg l-1 nd
1.6 µg l-1, respectively) (1 . Keller (185) studied the acute toxicity of several pesticides, among
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which toxaphene, to freshwater mussels (Anodonta imbecilic) and compared their sensitivities
to common test organisms such as Daphnia Magna, Cerio dubia and fathead minnow
(Pimephales promelas). The 96-h LC50 for A. imbecilis exposed to toxaphene was 0.74 mg l-1.
Compared to the other organisms tested, A. imbecilis i  less sensitive to toxaphene. The acute
toxicity for most aquatic organisms range from 1-40 µg l-1 for toxaphene (1). Interestingly,
addition of sediment to the test chambers drastically reduced the toxicity of toxaphene to A.
imbecilis, indicating differences in susceptibility of A. imbecilis to either sediment-bound or
aqueous concentrations of toxaphene.
The application of toxaphene as a piscicide to lakes has caused direct as well as indiret
damage to the ecosystem. Direct damage includes: the disappearance of target as well as
nontarget organisms inhabiting toxaphene exposed waters. Indirectly, application of toxaphene
resulted in some cases in the replacement of native organisms by a new population of
organisms thereby modifying the structure of the ecosystem. Miskimmin and Schindler (186)
examined the response to toxaphene application and stocking with a non-native fish species on
total chironomids, Chaoborus pp., and planktonic Cladocera in a mesotrophic lake (Peanut
Lake, north basin) and a eutrophic lake (Chatwin Lake) in central Alberta, Canada. The
response in these lakes was compared to a lake that had not been treated (Peanut Lake, south
basin). They studied some members of invertebrates prior to application of toxaphene during
1961-62 and examined the recovery of the community in the following 30 years by analysing
sediment cores from the lakes. They found that as a result of toxaphene application to Chatwin
Lake (0.0184 ppm), planktonic Cladocreans decreased in abundance and dominance changes
from small- to large-bodied types. Short-term effects in sediment cores from the treated Peanut
Lake (0.0075 ppm) were not detected. In the absence of native fish and during trout stocking,
large invertebrates became dominant in both treated lakes. Residual toxicity and/or predation
by stocked fish in both lakes probably caused low levels of Chaoborus pp. throughout the
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1960s. The long-term changes in invertebrates of both lakes was most probably a result of the
manipulation of fish communities rather then residual toxicity.
Mammalian toxicity
Table 10 gives an overview of the acute effects caused by exposure to toxaphene.
General toxicity
The majority of acute toxicity studies of toxaphene in mammals were conducted
between 1950 and 1980. As reviewed by Saleh (1), the acute LD50 of toxaphene to laboratory
mammals ranged from 5 to 1075 mg kg-1, depending on the species studied and the route of
exposure used. In addition, female rats appeared to be somewhat more sensitive to toxaphene
exposure than male rats. Among the most prominent symptoms observed in acutely intoxicated
laboratory animals by toxaphene are generalised epileptic-like convulsions, starting with
excessive saliva production, followed by vomiting and muscle spasms. In the course of time,
the frequency of convulsions increased. Finally, animals became exhausted and died because of
respiratory failure (173). Pathological changes upon toxaphene exposure may include
degeneration of the brain and spinal cord, pulmonary oedema (1).
Combination toxicity
Since toxaphene was widely used as a pesticide in addition to other pesticides, the toxicity of
toxaphene alone as well as in combination to other widely used pesticides was evaluated in
ICR mice after 14 days of oral administration or 90 days in drinking water (195,196). Ov rall,
decreases body weight as well as increases in lever/body weight ratios were observed in mice
exposed to toxaphene and toxaphene containing mixtures. Optically, no pathological changes
were observed in tissues from treated animals. However, proliferation along with dilatation and
fragmentation of the endoplasmatic reticulum and scattering of ribosomes in the liver were
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pronounced. Co-treatment of mice with toxaphene and parathion resulted in higher levels of
inhibition of serum cholinesterase (serum ChE) activity than treatment of mice with toxaphene
alone for up to 3 days after initial exposure. In contrast, an increase of serum ChE activity was
observed in mice co-treated with toxaphene and 2,4-D as compared to toxaphene alone. The
phenobarbital-induce sleeping time was reduced in mice exposed to toxaphene and toxaphene
containing mixtures, whereas in mice exposed to either one of the other pesticides no reduction
was observed. This was probably caused by the capability of toxaphene containing exposures
to induce the hepatic mixed-function oxygenase (MFO) system. From these studies it can not
be concluded that the combinatorial toxicity of toxaphene and other pesticides is synergistic or
antagonistic in nature, but rather a resultant of the effects showed by their components
individually.
Neurotoxicity
Neurotoxic effects of toxaphene exposure, such as effects on behaviour and learning have been
reported to occur (1). The mechanisms underlying neurotoxicity however are little understood.
In guinea pig, Chandra and Durairaj (194) observed histological changes in the brain, e.g.
hypoxic (disorganisation) and anoxic (enlargement) changes in the neurones, upon exposure to
toxaphene. Depletion of cytoplasmic organelles in the oligodendritic cells of the cerebrum was
observed in guinea pigs exposed to 2 mg kg-1 toxaphene whereas exposure to the high 5 mg
kg-1 day-1 dose resulted in disfigurement of myelin in the brain. In a subsequent study, Chandra
and Durairaj (197) investigated the impact of acute and subacute toxicity of toxaphene on the
lipid profile in brain, liver and kidney in guinea pig. In the brain, an increase in neutral lipids
and cholesterol and a reduction of phospholipids was observed. The individual
phosphoglycerides phosphatidylinositol, sphingomyelin and phosphatidic acid increased in both
the acute and subacutely intoxicated guinea pig brain. From their studies, Chandra and Durairaj
Geus, H.-J. de, et al. Toxaphene: occurrence, analysis and toxicology
54
(197) postulated that the observed effects of toxaphene on lipid contents in brain, liver and
kidney brought about membrane damage. In addition, alterations in phospholipids and
cholestrol content were thought to be an adaptive mechanism to cope with the stress due to
toxaphene intoxication. Furthermore, they argued that the increase of sphingomyelin in the
brain might be related to neurotoxic symptoms since an increase in sphingomyelin inhibits the
permeability of the membrane to small molecules and ions.
Chandra and Durairaj (184) also observed reduced ATPase and acetyl cholinesterase
(AchE) activities in the brain upon acute and subacute exposure of guinea pigs to similar
concentrations of toxaphene. Addressing the mode of action of the neurotoxic effects of
toxaphene, Chandra and Durairaj discussed that inhibition of acetyl cholinesterase can result in
neural and neuromuscular disorders. In addition, respiratory failure, leading to hypoxic and
anoxic changes, would eventually result in decreased phosphorylation and ATP production, as
evidenced by inhibition of ATPases. In vitro, toxaphene has been shown to inhibit brain and
kidney ATPases in mammals as well as in fish and insects (1). In contrast to the observed
effects on brain acetyl cholinesterase activity in the guinea pig, little effects on brain
cholinesterase activity were observed in mice treated with toxaphene and toxaphene containing
mixtures (195). The exposure of mice to toxaphene or a toxaphene containing mixture did not
result in pathological changes in brain and liver at the light microscopic level.
Table 11 gives an overview of neurological, reproductive, and endocrine effects caused
by exposure to toxaphene.
Nephrotoxicty
In a number of studies, the effects on the kidney of mammals exposed to toxaphene were
observed. In the 1992 study by Chandra and Durairaj (194),  single administration of 300 mg
toxaphene kg-1 b.w. to guinea pigs did not result in observable changes in the ultrastructure of
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the kidney, 72 h after exposure. In a subacute exposure study, administration of 2 or 6 mg
toxaphene kg-1 day-1 administered for 60 days revealed vacuolisation in cells of the collecting
system and glomerulus, degeneration of corticol tubular cells, vacuolisation and an increase in
the number of mitochondria of tubular epithelial. From this study, the authors evaluated the
toxaphene induced nephrotic changes as an adaptive mechanism of the guinea pig to cope with
a disturbance in membrane associated glycoproteins and glycolipid metabolism in liver and
kidney. Studying the impact of acute and subacute effects of toxaphene on the lipid profile in
kidney, Chandra and Durairaj (197) observed an increase in phosphatidylcholine,
phosphatidylinositol and phosphatidic acid levels which were accompanied with a decrease in
cardiolipin and sphingomyelin content. However, no alterations in other phosphoglyceride
contents were found. Both acute and subacute exposure of guinea pig resulted in reduced
ATPase and AchE activities in the kidney (184). This study also indicated that in addition to
the liver, toxaphene may be metabolised in the kidney since an enhanced cytochrome P-450
content and induced aniline hydroxylase activity was found in the kidney upon toxaphene
exposure.
Hepatotoxicity
A number of studies have shown that toxaphene or toxaph ne c ntaining mixtures are
capable of inducing a number of hepatic biotransformation enzymes. Toxaphene as well as
combinations of toxaphene with parathion (5 mg kg-1) and/or 2,4-D (50 mg kg-1) induced
hepatic enzymes such as cytochrome P450, benzo[a]pyrene hydroxylase and aliesterase in mice
after 7 days of oral exposure. Furthermore, the in vitro biotransformation of parathion and
paraoxon was effectively enhanced using hepatic 9000 g supernatant from mice exposed to
toxaphene (202). Toxaphene and toxaphene containing mixtures were also shown to decrease
the phenobarbital induced sleeping time in mice, suggesting an effect of toxaphene on CYP2B
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type metabolizing enzymes (195). These studies shown that the toxaphene induced increase of
appropriate biotransformation enzymes, among which cytochrome P-450, potentially
stimulates the metabolism of a number of other xenobiotics and as a consequence might even
reduce their toxicity.
In guinea pig, a single dose of 300 mg toxaphene kg-1 b.w. did not result in
histopathological or ultrastructural changes of the liver whereas administration of 2 or 5 mg
kg-1 day-1 for 60 days led to a relative increase in liver weight, chronic venous congestion,
mononuclear infiltration and fatty changes in hepatocytes (194). Th  effects of subacute
toxicity of 2 and 5 mg toxaphene kg-1 day-1 on the hepatic lipid profile was a decrease of
phospholipids without significant alterations in glycolipid, neutral lipids and cholestrol levels
(197). Markedly, in this study the acute dose of 300 mg kg-1 b.w. resulted in piloerection,
sedation, crouching, clonic-tonic convulsions and death within 72 h. The changes observed in
lipid profile were thought to be an adaptive mechanism to cope with stress due to toxaphene
intoxication. In a similar experiment, toxaphene was also shown to reduce hepatic ATPase and
acetyl cholinesterase activities and interfere with collagen and calcium metabolism (184).
Reproductive effects
Little data is available on the reproductive effects of toxaphene in mammals and fish. In
mammals little or no effects were found indicating interference of toxaphene with reproduction
(203-205). Recently, the reproductive effect of toxaphene in sexually mature female zebrafish
was studied after being fed toxaphene contaminated food (0.02, 0.23 and 2.2 µg g-1 fish day-1)
for two weeks (206). In the highest dose group, all fish died within 24 h and 9 out of 14 fish
died in the group exposed to 0.23 µg g-1 fish day-1 between day 8 and 12. Other toxic effects
observed in the parent fish were skin discoloration, subcutaneous hemorrhages and curved
backbones in the vertical plane. With regard to reproductive success, a non-significant
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decrease in mean total number of eggs spawned was observed. No differences in reproductive
success were observed as assessed by percentage of fertilised eggs 24 h after fertilisation,
percentage of embryo mortality and percentage hatching at 72 h after fertilisation. In contrast,
toxaphene produced a dose related decrease of the percentage of oviposition of female
zebrafish. Hence, it was concluded that dietary exposure of zebrafish to toxaphene affects the
reproductive process.
Endocrine toxicity
One of the recent concerns of many environmental pollutants is that they might have
endocrine-like properties. Environmental xenobiotics that mimic steroidal hormones have been
implicated in the increasing high incidence of breast cancer and other gender-specific disorders
(207-209). To determine whether environmental chemicals act as exogenous hormones in the
American alligator, Vonier et al. (210) examined the ability of chemicals to bind to the
estrogen receptor and progesterone receptor in a protein extract prepared from the oviduct of
the alligator. In contrast to some DDT metabolites, toxaphene did not interact with the
estrogen receptor. Interestingly, a combination of toxaphene with other chemicals decreased
[3H]17ß-estradiol binding in a greater than additive way.
Possible estrogenic or antiestrogenic potencies of toxaphene either alone or in
combination with other pesticides were however mainly studied in a number of in vitro systems
by other authors. The effect of toxaphene on the aromatase enzyme complex, which converts
androgenic to estrogenic enzymes, was studied by Drenth et al. (211) in the human
choriocarcinoma cell line JEG-3. Aromatses (CYP19) activity was not decreased as a result of
toxaphene exposure. The expression of estrogen-regulated mRNA stabilising factor (E-
RmRNASF) in toxaphene treated leghorn rooster liver was studied by determining the stability
of apolipoprotein II (apoII) mRNA in vitro. It was shown that toxaphene toxaphene prevented
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estrogen stimulation of E-RmRNASF expression, acting as an antiestrogen (212). Toxaphene
was also shown to inhibit the binding of progesterone, dexamethasone and testosterone to their
respective receptor (IC20 values of 68.4, 4.2, and 3.5 µM respectively), isolated from eggshell
gland mucosa of the domestic owl (213).
In contrast to the antiestrogenic potencies, weakly estrogenic potencies of toxaphene
was observed in a number of other in vitro test systems. In the human E-screen test, 10 mM
toxaphene showed to be weakly estrogenic (0.0001 as potent as estradiol). Interestingly, a
more than additive estrogenic response was observed in the human E-screen test after
administration of a mixture of 10 estrogenic chemicals including toxaphene (214,215). Usi g
transient gene expression studies employing a chimeric reporter construct containing one
estrogen-responsive element (ERE) controlling the expression of the chloramphenicol
acetyltransferase (CAT) gene in human breast cancer cells, technical toxaphene (10 µM) as
well as the toxaphene congener B[12012]-(212) (10 µM) were shown to act as antiestrogenes
which exert their effects by blocking the action of estrogens by inhibiting the ER:ERE
activated gene transcription (216).
In a study by Ramamoorthy et al. (217) minimal estrogenic potencies of toxaphene and
no synergistic effects of combinations of toxaphene and other pesticides were not observed.
Induction of CAT activity was not observed in MCF-7 human breast cancer cells transiently
transfected with plasmids containing estrogen-responsive 5’-promotor regions from either rat
creatine kinase B or human cathepsin D genes after treatment with toxaphene (10-8-10-5M) or
co-treated with toxaphene and dieldrin (equimolar concentrations, 10-5 M). Furthermore, no
estrogenic response in 21-day-old female B6C3F1 mouse uterus was observed after oral
exposure to toxaphene (2.5-275 mmol kg-1 body weight) or toxaphene in combination with
equimolar concentrations of dieldrin. In contrast to the above described sytems, the same
authors observed a slight estrogenic effect in an estrogen-responsive reporter system in yeast
Geus, H.-J. de, et al. Toxaphene: occurrence, analysis and toxicology
59
expressing mouse estrogen receptor, 2.5 h after treatment with toxaphene (2.5 10-5 M) or
mixtures of toxaphene with endosulfan, dieldrin or chlordane. The latter treatments were not
synergistic of nature. In contrast, no estrogenic effect was observed in yeast expressing human
estrogen receptor treated with toxaphene alone or in combination with other pesticides.
Carcinogenicity
Table 12 gives an overview of carcinogenic and mutagenic data of toxaphene presented in the
literature.
In the past, much effort has been put on studying the carcinogenic properties of
toxaphene. It was shown that toxaphene is highly carcinogenic in rat and mice inducing
malignant liver tumours, reticulum cell sarcomas, sarcomas in the uterus, neoplasms in the
reproductive system and/or mammary gland and neoplasms in the pituitary, adrenal gland and
the thyroid gland (1,177). The study in which neoplasms were found in the thyroid gland of the
rat were conducted by the National Cancer Institute (218). In order to investigate whether the
increased incidence in thyroid tumours seen in the rat in the National Cancer Institute bioassay
of toxaphene may have had a nongenotoxic aetiology, Waritz et al. (219) studied the thyroid
function and thyroid tumours in male Crl:Cd BR (Sprague-Dawley derived) rats orally exposed
to 75 mg toxaphene kg-1 day-1 for 28 days (the first 4 days, 100 mg toxaphene kg-1 day-1 was
administered). Rats were sacrificed at day 0, 7, 14 and 28 of exposure. A significant time-
dependent increase in serum TSH levels was found whereas serum levels of T3, T4, rT3 and
corrected rT3 did not change. They observed a time-dependent increase in thyroid follicular
cell hypertrophy and intrafollicular hyperplasia and a decrease in thyroid follicular cell colloid
stores, characteristic of a hyperactive thyroid. Considering the fact that toxaphene has the
characteristics of a PB-type inducer of the cytochrome P-450 enzyme system, the authors
concluded that the increase in thyroid follicular neoplasia in toxaphene treated rats was most
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probably caused by a nongenotoxic mechanism such as proposed for thyroid tumour increases
in rats chronically treated with PB. Since this type of mechanism for thyroid neoplasia is not
known to occur in humans, the authors also state that it becomes increasingly unlikely that
toxaphene presents a hazard as a thyroid carcinogen for humans.
In an attempt to further elucidate the mechanism of toxaphene-induced
hepatocarcinogenicity, Hedli et al. (224) investigated two potential mechanisms: peroxisomal
proliferation which has been invoked as a non-genotoxic mechanism of hepatocarcinogenicity,
and DNA adduct formation. After oral treatment of CD/1 mice for seven days with toxaphene
(0-100 mg kg-1), no increases in immunodetectable levels of CYP4A1 were detected,
suggesting that peroxisomal prolifereation is not involved in toxaphene’s toxicity.
Furthermore, no evidence for DNA adduct formation in the liver of toxaphene-treated mice
was found. Based on this study, the authors suggest that the hepatocarcinogenic properties of
toxaphene may be exerted via a non-genotoxic or promotional mechanism rather than a genetic
mechanism.
Although in vivo, no evidence for a genetic mechanism for toxaphene-induced tumor
formation was found, i  vitro studies showed that toxaphene is genotoxic in mammalian cell
systems and mutagenic in the Ames Salmonella test without requiring metabolic activation by
liver homogenates (1). More recently, Steinberg et al. (220) tested toxaphene and four
toxaphene congeners (B[12012]-(202), B[12012]-(212), B[30030]-(122) and B[30012]-(111))
for mutagenic activity in Salmonella typhimurium strains TA98 and TA 100 using a validated
microsuspension procedure instead of the usual plate incorporated procedure. Toxaphene was
found to be mutagenic only in the TA100 at concentration of 2500, 5000, and 10000 µg ml-1.
In contrast, toxaphene was also mutagenic to strain TA98 at a concentration of 10000 µg
plate-1 when using the plate incorporated assay. Using the microsuspension method, all four
tested toxaphene congeners did not show mutagenic activity in strain TA100 at any of the
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concentrations tested (maximum concentration: 10000 µg ml-1). A dose-dependent (10-10,000
mg plate-1) increase in His revertants was also observed in strains TA97, TA98, TA100, TA102
and TA104 by Schrader et al. (225) in the absence of S9 metabolic activation. Genotoxicity of
the technical toxaphene, as well as B[30012]-(111), but not B[12012]-(202), B[12012]-(212)
and B[30030]-(122), was also demonstrated by Boon et al. (128) using the Mutatox assay.
Addition of rat S9 fraction or microsomes of harbour seal and albatross, decreased the
genotoxic potential of the tested congeners and toxaphene. More in vitro evidence for
genotoxicity was found by Sobti et al. (226) showing toxaphene-induced sister-chromatid
exchange (SCE) in cultured lymphoblasts. In contrast, Schrader et al. (225) could not
demonstrate convincing evidence of a toxaphene-induced (1-10 µg ml-1) dose-dependent SCE
induction at the HGPRT gene locus in V79 cells.
Since cell-cycle delay may interfere with the expression of genotoxicity, Steinel et al.
(221) studied the effect of cell-cycle delay on the induction of SCE by toxaphene in Chinese
hamster lung (Don) cells. They found that toxaphene exhibited a dose- and time-dependent
decrease in cell-cycle progression. At similar concentrations of toxaphene higher numbers of
SCEs were observed and a dose- and treatment time-relationship was demonstrated. Hence,
SCE induced by toxaphene was not masked by mitotic delay and longer toxaphene treatment
times were not necessary in Don Chinese hamster cells. Nevertheless, the authors support the
recommendations for prolonged incubation times in SCE assays affected by mitotic delay.
 To study promotional mechanism rather than a genetic mechanism for toxaphene-
induce tumor formation, Kang et al. (222) studied the inhibition of gap junctional intercellular
communication (GJIC) by toxaphene. Non-cytotoxic concentrations of toxaphene (0-10 µg ml-
1) inhibited GJIC in normal human breast epithelial cells reversibly in a dose-dependent fashion
after 90 min of exposure. In an attempt to determine how toxaphene inhibited GJIC, Kang and
co-workers examined Cx43 protein in cells treated with toxaphene (222). A r duction in the
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number of gap junctional plaques and a induction of hypophosphorylation of Cx43 in normal
human breast epithelial cells was observed at toxaphene concentrations that affected GJIC. In
addition, these studies also shown that toxaphene inhibit GJIC via a nonestrogen receptor
mechanism since the cells used in these studies do not express the estrogen receptor. An
alternative working hypothesis has been proposed for skin-tumour promotion, suggesting a
central role for protein kinase C (PKC) (227). Moser and Smart (223) examined the potency of
some hepatocarcinogenic organochlorine pesticides to stimulate PKC in vitro in mouse brain,
hepatic, and epidermal homogenates. Two hundred µM toxaphene increased brain PKC 469-
fold. The induction was phospholipid and calcium dependent. From this result, it is premature
however to conclude that stimulation of PKC activity is involved in toxaphene induced
hepatic-tumour promotion.
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Toxaphene, a human risk factor
As mentioned earlier, toxaphene is carcinogenic in rats and mice and has been proven to be
mutagenic as well (1,178). Such findings led to the assumption that toxaphene poses a risk as a
human carcinogen. Human exposure to toxaphene mainly occurs through the consumption of
contaminated fish or occupational exposure. Data on the risk to humans associated with
toxaphene exposure is scarce (1). Brown et al. (228) and Cantor et al. (229) further evaluated
the association between elevated risk of leukemia and non-Hodgkin’s lymphoma (NHL)
among farmers and exposure to pesticides and other agricultural chemicals. Their results point
to an elevated risk of NHL amongst farmers. Risk increased in cases where farmers had
personally handled, mixed, or applied pesticides, did not use protecting clothes, and when
more specific definitions of pesticide exposure was used. With regard to the latter, chemicals
most strongly associated with risk of NHL were carbaryl, chlordane, DDT, diazinon,
dichlorvos, lindane, malathion, nicotine, and toxaphene.
Although studies like these contribute to our knowledge concerning the toxicity of
toxaphene to humans, difficulties arise in the interpretation of the human risk. In a IARC
evaluation of the carcinogenic risk of toxaphene to humans, toxaphene was regarded as if it
presented a carcinogenic risk to humans based on the evidence that toxaphene is carcinogenic
in rat and mice and despite the lack of adequate data in humans (230). However, so far most
studies on carcinogenicity of toxaphene have been performed with technical toxaphene
mixtures. Exposure of humans is however mainly through consumption of toxaphene
contaminated fish. The composition of the toxaphene mixture is changed from the original
technical mixture due to weathering conditions and internal metabolism. The real exposure of
humans is therefore to another mixture then technical toxaphene. It is not known what the
toxic and carcinogenic properties are of those fish-born residues of toxaphene. In the
framework of an EU-funded project “MATT”, our laboratories are involved in a joint effort to
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produce and isolate fish (cod)-based toxaphene residues which are chemically characterised
and toxicologically evaluated, particularly for genotoxicity (in vitro) and tumour promotion
capacity in a semi-chronic exposure study.
LEGISLATION OF TOXAPHENE IN FOOD
In 1976 a European Directive regulating residues of toxaphene in fruits and vegetables (0.4 mg
kg-1) was issued (231), which had to be integrated in the national food laws of all member
states. At that time toxaphene was still used as pesticide. In 1982 the European Maximum
residue limit (MRL) for fruits and vegetables was extended to some food from animal origin
such as meat and meat products, milk and milk products and animal edible fat in the German
MRL Ordinance (232). During that period no reports or data about toxaphene residues were
published. Based on toxicological concerns as toxaphene was internationally classified as a
compound possibly carcenogenic to humans (1), the European MRL for fruits and vegetables
was further reduced in 1993 to 0.1 mg kg-1 wet weight (233), equal to the limit of
determination (LOD) of common residue analysis methods. Thus residues of toxaphene should
not be found in these foods. In 1994 during the implementation of this regulation into the
German MRL Ordinance, this strict MRL was extended to all food from animal origin (234)
including fish and fish products. For fatty fish (lipid content >10%) the MRL was set at 0.1 mg
kg-1 lipid weight, for lean fish with a lipid content >10% the MRL at 0.01 mg kg-1 wet wei ht.
In general the above mentioned regulations were based on total toxaphene levels. Just
in the beginning of the nineties a sensitive residue analysis method by GC-ECD and GC-
NCI/MS using 3 individual chlorinated bornane congeners (B[12012]-(202), B[12012]-(212)
and B[30030]-(122)) was developed in Germany (11,92), applied in the routine analysis of
many German laboratories and validated by an interlaboratory exercise (99,235). First reports
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indicated relatively high concentrations of these toxaphene congeners were to be found in
some fish from the North Atlantic which is an area from which much of Germany’s fish stocks
are derived (100). It was obvious that some for the consumer relevant fish would exceed this
low MRL. Therefore, the new regulation for fish, fish products and mussels was suspended till
the end of 1996 (234,236) to give the legislator the possibility to check, which MRL has to be
established that takes into account the question of an acceptable level of consumer protection
and on the other hand the necessary supply of the population with fish and fish products. In the
interim much data about the contamination of all for the consumer relevant fish by the 3
indicator congeners was collected and evaluated in order to calculate the average toxaphene
intake by fish consumption (0.22 µg person-1 day-1) (237). At present there exists no
acceptable daily intake (ADI) value for toxaphene for carrying out a risk assessment.
Therefore, the average toxaphene intake was compared with the lowest no observed adverse
effect level (NOAEL) considering a sufficient high safety factor (ca. 25,000-50,000). In 1997
the German MRL for toxaphene in food from animal origin was then established with a new
concept. The MRL for fish and fish products was set at 0.1 mg kg-1 wet weight on the basis of
the sum of the 3 indicator congeners (238), for all other food from animal origin at 0.1 mg kg-1
on the basis of total toxaphene. It is the intention of the German government to fix also this
latter MRL in future on the basis of the toxaphene indicator congener concept. It is the first
national MRL for fish on the basis of toxaphene congeners.
Tolerance levels for toxaphene with regard to food consumption by humans in other
countries are only known from the USA and Canada. The USA tolerance level was 5 mg kg-1
wet weight, however, this USA tolerance level has been withdrawn a few years ago. In Canada
instead of a tolerance level an ADI value of 0.2 µg kg-1 body weight is used. The calculated
daily intake values from the results of Alder et al. (100) st y below this Canadian ADI.
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